 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0004687	myosin light chain kinase activity	1	2.135699e-4	7.876458e-1	7.876458e-1	4.682308e+3	2.135699e-4	1	2.135699e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MYLK2
GO Molecular Function	GO:0004683	calmodulin-dependent protein kinase activity	2	2.089267e-3	1.000000e+0	1.000000e+0	4.786368e+2	2.089267e-3	1	2.089267e-3	1.000000e+0	2	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	MYLK2
GO Molecular Function	GO:0005516	calmodulin binding	3	2.165965e-2	1.000000e+0	1.000000e+0	4.616879e+1	2.165965e-2	1	2.165965e-2	1.000000e+0	17	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	MYLK2
GO Molecular Function	GO:0005525	GTP binding	4	3.159021e-2	1.000000e+0	1.000000e+0	3.165538e+1	3.159021e-2	1	3.159021e-2	1.000000e+0	20	4.070677e-2	1.000000e+0	1.000000e+0	2.431402e+1	4.112854e-2	1	371	5.000000e-1	2.695418e-3	unnamed	TPX2
GO Molecular Function	GO:0032561	guanyl ribonucleotide binding	5	3.406999e-2	1.000000e+0	1.000000e+0	2.935135e+1	3.406999e-2	1	3.406999e-2	1.000000e+0	22	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	TPX2
GO Molecular Function	GO:0019901	protein kinase binding	6	3.996582e-2	1.000000e+0	1.000000e+0	2.502138e+1	3.996582e-2	1	3.996582e-2	1.000000e+0	21	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	TPX2
GO Molecular Function	GO:0019900	kinase binding	7	4.338612e-2	1.000000e+0	1.000000e+0	2.304885e+1	4.338612e-2	1	4.338612e-2	1.000000e+0	23	4.612818e-2	1.000000e+0	1.000000e+0	2.142637e+1	4.667147e-2	1	421	5.000000e-1	2.375297e-3	unnamed	TPX2
GO Molecular Function	GO:0004674	protein serine/threonine kinase activity	8	4.546205e-2	1.000000e+0	1.000000e+0	2.199637e+1	4.546205e-2	1	4.546205e-2	1.000000e+0	24	4.764342e-2	1.000000e+0	1.000000e+0	2.073678e+1	4.822349e-2	1	435	5.000000e-1	2.298851e-3	unnamed	MYLK2
GO Molecular Function	GO:0004672	protein kinase activity	9	6.766371e-2	1.000000e+0	1.000000e+0	1.477897e+1	6.766371e-2	1	6.766371e-2	1.000000e+0	25	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	MYLK2
GO Molecular Function	GO:0016773	phosphotransferase activity, alcohol group as acceptor	10	7.689902e-2	1.000000e+0	1.000000e+0	1.300407e+1	7.689902e-2	1	7.689902e-2	1.000000e+0	26	7.694989e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	MYLK2
GO Molecular Function	GO:0016301	kinase activity	11	8.718065e-2	1.000000e+0	1.000000e+0	1.147044e+1	8.718065e-2	1	8.718065e-2	1.000000e+0	29	8.979273e-2	1.000000e+0	1.000000e+0	1.088118e+1	9.190178e-2	1	829	5.000000e-1	1.206273e-3	unnamed	MYLK2
GO Molecular Function	GO:0016772	transferase activity, transferring phosphorus-containing groups	12	9.593868e-2	1.000000e+0	1.000000e+0	1.042332e+1	9.593868e-2	1	9.593868e-2	1.000000e+0	30	1.047497e-1	1.000000e+0	1.000000e+0	9.289907e+0	1.076437e-1	1	971	5.000000e-1	1.029866e-3	unnamed	MYLK2
GO Molecular Function	GO:0019899	enzyme binding	13	1.157271e-1	1.000000e+0	1.000000e+0	8.641016e+0	1.157271e-1	1	1.157271e-1	1.000000e+0	32	1.255021e-1	1.000000e+0	1.000000e+0	7.709829e+0	1.297046e-1	1	1170	5.000000e-1	8.547009e-4	unnamed	TPX2
GO Molecular Function	GO:0005524	ATP binding	14	1.376192e-1	1.000000e+0	1.000000e+0	7.266427e+0	1.376192e-1	1	1.376192e-1	1.000000e+0	3	6.635016e-3	1.000000e+0	1.000000e+0	1.227279e+1	1.629621e-1	2	1470	1.000000e+0	1.360544e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0032559	adenyl ribonucleotide binding	15	1.426806e-1	1.000000e+0	1.000000e+0	7.008664e+0	1.426806e-1	1	1.426806e-1	1.000000e+0	4	6.927132e-3	1.000000e+0	1.000000e+0	1.201132e+1	1.665096e-1	2	1502	1.000000e+0	1.331558e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0030554	adenyl nucleotide binding	16	1.431520e-1	1.000000e+0	1.000000e+0	6.985581e+0	1.431520e-1	1	1.431520e-1	1.000000e+0	5	7.066228e-3	1.000000e+0	1.000000e+0	1.189255e+1	1.681725e-1	2	1517	1.000000e+0	1.318392e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0035639	purine ribonucleoside triphosphate binding	17	1.642264e-1	1.000000e+0	1.000000e+0	6.089156e+0	1.642264e-1	1	1.642264e-1	1.000000e+0	6	1.002718e-2	1.000000e+0	1.000000e+0	9.983951e+0	2.003215e-1	2	1807	1.000000e+0	1.106807e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0032550	purine ribonucleoside binding	18	1.650919e-1	1.000000e+0	1.000000e+0	6.057234e+0	1.650919e-1	1	1.650919e-1	1.000000e+0	7	1.012734e-2	1.000000e+0	1.000000e+0	9.934471e+0	2.013192e-1	2	1816	1.000000e+0	1.101322e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0001883	purine nucleoside binding	19	1.651911e-1	1.000000e+0	1.000000e+0	6.053594e+0	1.651911e-1	1	1.651911e-1	1.000000e+0	8	1.016084e-2	1.000000e+0	1.000000e+0	9.918087e+0	2.016518e-1	2	1819	1.000000e+0	1.099505e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0032549	ribonucleoside binding	20	1.652867e-1	1.000000e+0	1.000000e+0	6.050092e+0	1.652867e-1	1	1.652867e-1	1.000000e+0	9	1.017201e-2	1.000000e+0	1.000000e+0	9.912637e+0	2.017627e-1	2	1820	1.000000e+0	1.098901e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0001882	nucleoside binding	21	1.658155e-1	1.000000e+0	1.000000e+0	6.030800e+0	1.658155e-1	1	1.658155e-1	1.000000e+0	10	1.028413e-2	1.000000e+0	1.000000e+0	9.858470e+0	2.028712e-1	2	1830	1.000000e+0	1.092896e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0032555	purine ribonucleotide binding	22	1.693981e-1	1.000000e+0	1.000000e+0	5.903255e+0	1.693981e-1	1	1.693981e-1	1.000000e+0	11	1.045346e-2	1.000000e+0	1.000000e+0	9.778320e+0	2.045341e-1	2	1845	1.000000e+0	1.084011e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0017076	purine nucleotide binding	23	1.701196e-1	1.000000e+0	1.000000e+0	5.878217e+0	1.701196e-1	1	1.701196e-1	1.000000e+0	13	1.064704e-2	1.000000e+0	1.000000e+0	9.689044e+0	2.064187e-1	2	1862	1.000000e+0	1.074114e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0032553	ribonucleotide binding	24	1.708664e-1	1.000000e+0	1.000000e+0	5.852525e+0	1.708664e-1	1	1.708664e-1	1.000000e+0	12	1.061275e-2	1.000000e+0	1.000000e+0	9.704680e+0	2.060861e-1	2	1859	1.000000e+0	1.075847e-3	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0016740	transferase activity	25	1.774445e-1	1.000000e+0	1.000000e+0	5.635566e+0	1.774445e-1	1	1.774445e-1	1.000000e+0	33	1.943792e-1	1.000000e+0	1.000000e+0	4.881223e+0	2.048667e-1	1	1848	5.000000e-1	5.411255e-4	unnamed	MYLK2
GO Molecular Function	GO:0097367	carbohydrate derivative binding	26	1.996235e-1	1.000000e+0	1.000000e+0	5.009431e+0	1.996235e-1	1	1.996235e-1	1.000000e+0	14	1.405146e-2	1.000000e+0	1.000000e+0	8.434315e+0	2.371265e-1	2	2139	1.000000e+0	9.350164e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0000166	nucleotide binding	27	2.080686e-1	1.000000e+0	1.000000e+0	4.806107e+0	2.080686e-1	1	2.080686e-1	1.000000e+0	15	1.645952e-2	1.000000e+0	1.000000e+0	7.793089e+0	2.566377e-1	2	2315	1.000000e+0	8.639309e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:1901265	nucleoside phosphate binding	28	2.081652e-1	1.000000e+0	1.000000e+0	4.803877e+0	2.081652e-1	1	2.081652e-1	1.000000e+0	16	1.647375e-2	1.000000e+0	1.000000e+0	7.789724e+0	2.567485e-1	2	2316	1.000000e+0	8.635579e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0036094	small molecule binding	29	2.286651e-1	1.000000e+0	1.000000e+0	4.373209e+0	2.286651e-1	1	2.286651e-1	1.000000e+0	18	2.023883e-2	1.000000e+0	1.000000e+0	7.028048e+0	2.845740e-1	2	2567	1.000000e+0	7.791196e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0043168	anion binding	30	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	19	2.280744e-2	1.000000e+0	1.000000e+0	6.620550e+0	3.020897e-1	2	2725	1.000000e+0	7.339450e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:1901363	heterocyclic compound binding	31	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	27	8.629242e-2	1.000000e+0	1.000000e+0	3.403962e+0	5.875506e-1	2	5300	1.000000e+0	3.773585e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0097159	organic cyclic compound binding	32	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	28	8.868613e-2	1.000000e+0	1.000000e+0	3.357714e+0	5.956433e-1	2	5373	1.000000e+0	3.722315e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0003824	catalytic activity	33	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	36	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	MYLK2
GO Molecular Function	GO:0043167	ion binding	34	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	31	1.118514e-1	1.000000e+0	1.000000e+0	2.989891e+0	6.689208e-1	2	6034	1.000000e+0	3.314551e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0005515	protein binding	35	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	34	1.964729e-1	1.000000e+0	1.000000e+0	2.255971e+0	8.865362e-1	2	7997	1.000000e+0	2.500938e-4	unnamed	MYLK2,TPX2
GO Molecular Function	GO:0005488	binding	36	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	35	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0032971	regulation of muscle filament sliding	1	7.692455e-5	8.030923e-1	8.030923e-1	1.299975e+4	7.692455e-5	1	7.692455e-5	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MYLK2
GO Biological Process	GO:0060236	regulation of mitotic spindle organization	2	1.879002e-4	1.000000e+0	9.808390e-1	5.321975e+3	1.879002e-4	1	1.879002e-4	1.000000e+0	3	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	TPX2
GO Biological Process	GO:0014816	satellite cell differentiation	3	4.255639e-4	1.000000e+0	1.000000e+0	2.349823e+3	4.255639e-4	1	4.255639e-4	1.000000e+0	2	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MYLK2
GO Biological Process	GO:0090224	regulation of spindle organization	4	4.505032e-4	1.000000e+0	1.000000e+0	2.219740e+3	4.505032e-4	1	4.505032e-4	1.000000e+0	4	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	TPX2
GO Biological Process	GO:0007274	neuromuscular synaptic transmission	5	1.837328e-3	1.000000e+0	1.000000e+0	5.442687e+2	1.837328e-3	1	1.837328e-3	1.000000e+0	5	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	MYLK2
GO Biological Process	GO:0060048	cardiac muscle contraction	6	4.590221e-3	1.000000e+0	1.000000e+0	2.178544e+2	4.590221e-3	1	4.590221e-3	1.000000e+0	8	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	MYLK2
GO Biological Process	GO:0018107	peptidyl-threonine phosphorylation	7	4.617804e-3	1.000000e+0	1.000000e+0	2.165531e+2	4.617804e-3	1	4.617804e-3	1.000000e+0	6	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	MYLK2
GO Biological Process	GO:0018210	peptidyl-threonine modification	8	5.243882e-3	1.000000e+0	1.000000e+0	1.906984e+2	5.243882e-3	1	5.243882e-3	1.000000e+0	7	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	MYLK2
GO Biological Process	GO:0060047	heart contraction	9	5.409111e-3	1.000000e+0	1.000000e+0	1.848733e+2	5.409111e-3	1	5.409111e-3	1.000000e+0	9	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	MYLK2
GO Biological Process	GO:0035914	skeletal muscle cell differentiation	10	5.802611e-3	1.000000e+0	1.000000e+0	1.723362e+2	5.802611e-3	1	5.802611e-3	1.000000e+0	10	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	MYLK2
GO Biological Process	GO:0003015	heart process	11	6.478089e-3	1.000000e+0	1.000000e+0	1.543665e+2	6.478089e-3	1	6.478089e-3	1.000000e+0	11	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MYLK2
GO Biological Process	GO:0006941	striated muscle contraction	12	6.647846e-3	1.000000e+0	1.000000e+0	1.504247e+2	6.647846e-3	1	6.647846e-3	1.000000e+0	15	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	MYLK2
GO Biological Process	GO:0055008	cardiac muscle tissue morphogenesis	13	9.507190e-3	1.000000e+0	1.000000e+0	1.051836e+2	9.507190e-3	1	9.507190e-3	1.000000e+0	12	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	MYLK2
GO Biological Process	GO:0060415	muscle tissue morphogenesis	14	1.019621e-2	1.000000e+0	1.000000e+0	9.807562e+1	1.019621e-2	1	1.019621e-2	1.000000e+0	13	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MYLK2
GO Biological Process	GO:0070507	regulation of microtubule cytoskeleton organization	15	1.043375e-2	1.000000e+0	1.000000e+0	9.584283e+1	1.043375e-2	1	1.043375e-2	1.000000e+0	17	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	TPX2
GO Biological Process	GO:0048644	muscle organ morphogenesis	16	1.085339e-2	1.000000e+0	1.000000e+0	9.213711e+1	1.085339e-2	1	1.085339e-2	1.000000e+0	14	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MYLK2
GO Biological Process	GO:0032886	regulation of microtubule-based process	17	1.197356e-2	1.000000e+0	1.000000e+0	8.351733e+1	1.197356e-2	1	1.197356e-2	1.000000e+0	19	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	TPX2
GO Biological Process	GO:0055007	cardiac muscle cell differentiation	18	1.329217e-2	1.000000e+0	1.000000e+0	7.523225e+1	1.329217e-2	1	1.329217e-2	1.000000e+0	16	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	MYLK2
GO Biological Process	GO:0007519	skeletal muscle tissue development	19	1.469101e-2	1.000000e+0	1.000000e+0	6.806882e+1	1.469101e-2	1	1.469101e-2	1.000000e+0	21	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	MYLK2
GO Biological Process	GO:0060538	skeletal muscle organ development	20	1.558882e-2	1.000000e+0	1.000000e+0	6.414853e+1	1.558882e-2	1	1.558882e-2	1.000000e+0	22	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	MYLK2
GO Biological Process	GO:0035051	cardiocyte differentiation	21	1.721953e-2	1.000000e+0	1.000000e+0	5.807360e+1	1.721953e-2	1	1.721953e-2	1.000000e+0	18	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	MYLK2
GO Biological Process	GO:0046777	protein autophosphorylation	22	1.778940e-2	1.000000e+0	1.000000e+0	5.621326e+1	1.778940e-2	1	1.778940e-2	1.000000e+0	28	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	MYLK2
GO Biological Process	GO:0006937	regulation of muscle contraction	23	1.867020e-2	1.000000e+0	1.000000e+0	5.356128e+1	1.867020e-2	1	1.867020e-2	1.000000e+0	25	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	MYLK2
GO Biological Process	GO:0048738	cardiac muscle tissue development	24	2.162079e-2	1.000000e+0	1.000000e+0	4.625178e+1	2.162079e-2	1	2.162079e-2	1.000000e+0	24	1.447015e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	MYLK2
GO Biological Process	GO:0051146	striated muscle cell differentiation	25	2.241822e-2	1.000000e+0	1.000000e+0	4.460658e+1	2.241822e-2	1	2.241822e-2	1.000000e+0	27	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	MYLK2
GO Biological Process	GO:0090257	regulation of muscle system process	26	2.283758e-2	1.000000e+0	1.000000e+0	4.378747e+1	2.283758e-2	1	2.283758e-2	1.000000e+0	26	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	MYLK2
GO Biological Process	GO:0006936	muscle contraction	27	2.298877e-2	1.000000e+0	1.000000e+0	4.349949e+1	2.298877e-2	1	2.298877e-2	1.000000e+0	30	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	MYLK2
GO Biological Process	GO:0007067	mitosis	28	2.800485e-2	1.000000e+0	1.000000e+0	3.570810e+1	2.800485e-2	1	2.800485e-2	1.000000e+0	42	3.385392e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	308	5.000000e-1	3.246753e-3	unnamed	TPX2
GO Biological Process	GO:0003012	muscle system process	29	2.838486e-2	1.000000e+0	1.000000e+0	3.523005e+1	2.838486e-2	1	2.838486e-2	1.000000e+0	34	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	MYLK2
GO Biological Process	GO:0032147	activation of protein kinase activity	30	2.941099e-2	1.000000e+0	1.000000e+0	3.400089e+1	2.941099e-2	1	2.941099e-2	1.000000e+0	34	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	TPX2
GO Biological Process	GO:0032970	regulation of actin filament-based process	31	3.000570e-2	1.000000e+0	1.000000e+0	3.332700e+1	3.000570e-2	1	3.000570e-2	1.000000e+0	32	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	MYLK2
GO Biological Process	GO:0048285	organelle fission	32	3.075653e-2	1.000000e+0	1.000000e+0	3.251342e+1	3.075653e-2	1	3.075653e-2	1.000000e+0	44	3.668503e-2	1.000000e+0	1.000000e+0	2.700749e+1	3.702677e-2	1	334	5.000000e-1	2.994012e-3	unnamed	TPX2
GO Biological Process	GO:0003007	heart morphogenesis	33	3.155445e-2	1.000000e+0	1.000000e+0	3.169125e+1	3.155445e-2	1	3.155445e-2	1.000000e+0	29	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MYLK2
GO Biological Process	GO:0007346	regulation of mitotic cell cycle	34	3.175872e-2	1.000000e+0	1.000000e+0	3.148741e+1	3.175872e-2	1	3.175872e-2	1.000000e+0	43	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	TPX2
GO Biological Process	GO:0051493	regulation of cytoskeleton organization	35	3.297347e-2	1.000000e+0	1.000000e+0	3.032741e+1	3.297347e-2	1	3.297347e-2	1.000000e+0	41	3.243680e-2	1.000000e+0	1.000000e+0	3.057797e+1	3.270329e-2	1	295	5.000000e-1	3.389831e-3	unnamed	TPX2
GO Biological Process	GO:0008015	blood circulation	36	3.353044e-2	1.000000e+0	1.000000e+0	2.982364e+1	3.353044e-2	1	3.353044e-2	1.000000e+0	39	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	MYLK2
GO Biological Process	GO:0003013	circulatory system process	37	3.378328e-2	1.000000e+0	1.000000e+0	2.960044e+1	3.378328e-2	1	3.378328e-2	1.000000e+0	40	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	MYLK2
GO Biological Process	GO:0042692	muscle cell differentiation	38	3.407161e-2	1.000000e+0	1.000000e+0	2.934995e+1	3.407161e-2	1	3.407161e-2	1.000000e+0	31	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	MYLK2
GO Biological Process	GO:0007517	muscle organ development	39	3.489956e-2	1.000000e+0	1.000000e+0	2.865365e+1	3.489956e-2	1	3.489956e-2	1.000000e+0	38	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	MYLK2
GO Biological Process	GO:0014706	striated muscle tissue development	40	3.543065e-2	1.000000e+0	1.000000e+0	2.822415e+1	3.543065e-2	1	3.543065e-2	1.000000e+0	33	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	MYLK2
GO Biological Process	GO:0032386	regulation of intracellular transport	41	3.683590e-2	1.000000e+0	1.000000e+0	2.714743e+1	3.683590e-2	1	3.683590e-2	1.000000e+0	45	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	MYLK2
GO Biological Process	GO:0060537	muscle tissue development	42	3.787799e-2	1.000000e+0	1.000000e+0	2.640055e+1	3.787799e-2	1	3.787799e-2	1.000000e+0	37	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	MYLK2
GO Biological Process	GO:0010564	regulation of cell cycle process	43	3.998440e-2	1.000000e+0	1.000000e+0	2.500975e+1	3.998440e-2	1	3.998440e-2	1.000000e+0	47	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	TPX2
GO Biological Process	GO:0048863	stem cell differentiation	44	4.181685e-2	1.000000e+0	1.000000e+0	2.391380e+1	4.181685e-2	1	4.181685e-2	1.000000e+0	36	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	MYLK2
GO Biological Process	GO:0051301	cell division	45	4.487060e-2	1.000000e+0	1.000000e+0	2.228631e+1	4.487060e-2	1	4.487060e-2	1.000000e+0	51	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	TPX2
GO Biological Process	GO:0045860	positive regulation of protein kinase activity	46	4.892278e-2	1.000000e+0	1.000000e+0	2.044038e+1	4.892278e-2	1	4.892278e-2	1.000000e+0	50	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	TPX2
GO Biological Process	GO:0033674	positive regulation of kinase activity	47	5.121151e-2	1.000000e+0	1.000000e+0	1.952686e+1	5.121151e-2	1	5.121151e-2	1.000000e+0	52	5.002208e-2	1.000000e+0	1.000000e+0	1.973851e+1	5.066238e-2	1	457	5.000000e-1	2.188184e-3	unnamed	TPX2
GO Biological Process	GO:0051347	positive regulation of transferase activity	48	5.276106e-2	1.000000e+0	1.000000e+0	1.895337e+1	5.276106e-2	1	5.276106e-2	1.000000e+0	53	5.131828e-2	1.000000e+0	1.000000e+0	1.923348e+1	5.199268e-2	1	469	5.000000e-1	2.132196e-3	unnamed	TPX2
GO Biological Process	GO:0000278	mitotic cell cycle	49	5.694180e-2	1.000000e+0	1.000000e+0	1.756179e+1	5.694180e-2	1	5.694180e-2	1.000000e+0	66	7.161666e-2	1.000000e+0	1.000000e+0	1.370897e+1	7.294496e-2	1	658	5.000000e-1	1.519757e-3	unnamed	TPX2
GO Biological Process	GO:0061061	muscle structure development	50	5.824539e-2	1.000000e+0	1.000000e+0	1.716874e+1	5.824539e-2	1	5.824539e-2	1.000000e+0	49	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	MYLK2
GO Biological Process	GO:0007507	heart development	51	6.055164e-2	1.000000e+0	1.000000e+0	1.651483e+1	6.055164e-2	1	6.055164e-2	1.000000e+0	48	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	MYLK2
GO Biological Process	GO:0033043	regulation of organelle organization	52	6.090903e-2	1.000000e+0	1.000000e+0	1.641793e+1	6.090903e-2	1	6.090903e-2	1.000000e+0	59	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	TPX2
GO Biological Process	GO:0018193	peptidyl-amino acid modification	53	6.275838e-2	1.000000e+0	1.000000e+0	1.593413e+1	6.275838e-2	1	6.275838e-2	1.000000e+0	58	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	MYLK2
GO Biological Process	GO:0001934	positive regulation of protein phosphorylation	54	6.805954e-2	1.000000e+0	1.000000e+0	1.469302e+1	6.805954e-2	1	6.805954e-2	1.000000e+0	60	6.562521e-2	1.000000e+0	1.000000e+0	1.498422e+1	6.673688e-2	1	602	5.000000e-1	1.661130e-3	unnamed	TPX2
GO Biological Process	GO:0044057	regulation of system process	55	6.822429e-2	1.000000e+0	1.000000e+0	1.465754e+1	6.822429e-2	1	6.822429e-2	1.000000e+0	55	5.390802e-2	1.000000e+0	1.000000e+0	1.829716e+1	5.465329e-2	1	493	5.000000e-1	2.028398e-3	unnamed	MYLK2
GO Biological Process	GO:0045859	regulation of protein kinase activity	56	6.845569e-2	1.000000e+0	1.000000e+0	1.460799e+1	6.845569e-2	1	6.845569e-2	1.000000e+0	64	7.076192e-2	1.000000e+0	1.000000e+0	1.387769e+1	7.205809e-2	1	650	5.000000e-1	1.538462e-3	unnamed	TPX2
GO Biological Process	GO:0042327	positive regulation of phosphorylation	57	7.047180e-2	1.000000e+0	1.000000e+0	1.419007e+1	7.047180e-2	1	7.047180e-2	1.000000e+0	63	6.723196e-2	1.000000e+0	1.000000e+0	1.461994e+1	6.839976e-2	1	617	5.000000e-1	1.620746e-3	unnamed	TPX2
GO Biological Process	GO:0051270	regulation of cellular component movement	58	7.158871e-2	1.000000e+0	1.000000e+0	1.396868e+1	7.158871e-2	1	7.158871e-2	1.000000e+0	56	5.627884e-2	1.000000e+0	1.000000e+0	1.751553e+1	5.709218e-2	1	515	5.000000e-1	1.941748e-3	unnamed	MYLK2
GO Biological Process	GO:0043549	regulation of kinase activity	59	7.376474e-2	1.000000e+0	1.000000e+0	1.355661e+1	7.376474e-2	1	7.376474e-2	1.000000e+0	69	7.481844e-2	1.000000e+0	1.000000e+0	1.311119e+1	7.627072e-2	1	688	5.000000e-1	1.453488e-3	unnamed	TPX2
GO Biological Process	GO:0051726	regulation of cell cycle	60	7.419191e-2	1.000000e+0	1.000000e+0	1.347856e+1	7.419191e-2	1	7.419191e-2	1.000000e+0	71	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	TPX2
GO Biological Process	GO:0048729	tissue morphogenesis	61	7.459408e-2	1.000000e+0	1.000000e+0	1.340589e+1	7.459408e-2	1	7.459408e-2	1.000000e+0	54	5.261359e-2	1.000000e+0	1.000000e+0	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	MYLK2
GO Biological Process	GO:0006468	protein phosphorylation	62	7.520909e-2	1.000000e+0	1.000000e+0	1.329626e+1	7.520909e-2	1	7.520909e-2	1.000000e+0	65	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	MYLK2
GO Biological Process	GO:0008283	cell proliferation	63	7.535461e-2	1.000000e+0	1.000000e+0	1.327059e+1	7.535461e-2	1	7.535461e-2	1.000000e+0	61	6.573237e-2	1.000000e+0	1.000000e+0	1.495937e+1	6.684774e-2	1	603	5.000000e-1	1.658375e-3	unnamed	TPX2
GO Biological Process	GO:0051338	regulation of transferase activity	64	7.596729e-2	1.000000e+0	1.000000e+0	1.316356e+1	7.596729e-2	1	7.596729e-2	1.000000e+0	72	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	TPX2
GO Biological Process	GO:0045937	positive regulation of phosphate metabolic process	65	8.017370e-2	1.000000e+0	1.000000e+0	1.247292e+1	8.017370e-2	1	8.017370e-2	1.000000e+0	70	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	TPX2
GO Biological Process	GO:0007268	synaptic transmission	66	8.253688e-2	1.000000e+0	1.000000e+0	1.211580e+1	8.253688e-2	1	8.253688e-2	1.000000e+0	57	6.283692e-2	1.000000e+0	1.000000e+0	1.566059e+1	6.385455e-2	1	576	5.000000e-1	1.736111e-3	unnamed	MYLK2
GO Biological Process	GO:0031401	positive regulation of protein modification process	67	8.358603e-2	1.000000e+0	1.000000e+0	1.196372e+1	8.358603e-2	1	8.358603e-2	1.000000e+0	76	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	TPX2
GO Biological Process	GO:0022402	cell cycle process	68	8.847677e-2	1.000000e+0	1.000000e+0	1.130240e+1	8.847677e-2	1	8.847677e-2	1.000000e+0	84	1.077891e-1	1.000000e+0	1.000000e+0	9.020500e+0	1.108586e-1	1	1000	5.000000e-1	1.000000e-3	unnamed	TPX2
GO Biological Process	GO:0032270	positive regulation of cellular protein metabolic process	69	9.043716e-2	1.000000e+0	1.000000e+0	1.105740e+1	9.043716e-2	1	9.043716e-2	1.000000e+0	79	9.433504e-2	1.000000e+0	1.000000e+0	1.034461e+1	9.666870e-2	1	872	5.000000e-1	1.146789e-3	unnamed	TPX2
GO Biological Process	GO:0060341	regulation of cellular localization	70	9.081570e-2	1.000000e+0	1.000000e+0	1.101131e+1	9.081570e-2	1	9.081570e-2	1.000000e+0	75	8.354176e-2	1.000000e+0	1.000000e+0	1.171494e+1	8.536112e-2	1	770	5.000000e-1	1.298701e-3	unnamed	MYLK2
GO Biological Process	GO:0019226	transmission of nerve impulse	71	9.296328e-2	1.000000e+0	1.000000e+0	1.075694e+1	9.296328e-2	1	9.296328e-2	1.000000e+0	67	7.183029e-2	1.000000e+0	1.000000e+0	1.366742e+1	7.316668e-2	1	660	5.000000e-1	1.515152e-3	unnamed	MYLK2
GO Biological Process	GO:0001932	regulation of protein phosphorylation	72	9.602533e-2	1.000000e+0	1.000000e+0	1.041392e+1	9.602533e-2	1	9.602533e-2	1.000000e+0	78	9.401850e-2	1.000000e+0	1.000000e+0	1.038032e+1	9.633612e-2	1	869	5.000000e-1	1.150748e-3	unnamed	TPX2
GO Biological Process	GO:0035637	multicellular organismal signaling	73	9.654494e-2	1.000000e+0	1.000000e+0	1.035787e+1	9.654494e-2	1	9.654494e-2	1.000000e+0	68	7.439186e-2	1.000000e+0	1.000000e+0	1.318787e+1	7.582728e-2	1	684	5.000000e-1	1.461988e-3	unnamed	MYLK2
GO Biological Process	GO:0006915	apoptotic process	74	9.852721e-2	1.000000e+0	1.000000e+0	1.014948e+1	9.852721e-2	1	9.852721e-2	1.000000e+0	85	1.119728e-1	1.000000e+0	1.000000e+0	8.673558e+0	1.152929e-1	1	1040	5.000000e-1	9.615385e-4	unnamed	TPX2
GO Biological Process	GO:0016310	phosphorylation	75	9.897799e-2	1.000000e+0	1.000000e+0	1.010326e+1	9.897799e-2	1	9.897799e-2	1.000000e+0	83	1.044350e-1	1.000000e+0	1.000000e+0	9.318698e+0	1.073111e-1	1	968	5.000000e-1	1.033058e-3	unnamed	MYLK2
GO Biological Process	GO:0012501	programmed cell death	76	1.001273e-1	1.000000e+0	1.000000e+0	9.987290e+0	1.001273e-1	1	1.001273e-1	1.000000e+0	86	1.134348e-1	1.000000e+0	1.000000e+0	8.558349e+0	1.168450e-1	1	1054	5.000000e-1	9.487666e-4	unnamed	TPX2
GO Biological Process	GO:0051247	positive regulation of protein metabolic process	77	1.002750e-1	1.000000e+0	1.000000e+0	9.972575e+0	1.002750e-1	1	1.002750e-1	1.000000e+0	82	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	TPX2
GO Biological Process	GO:0042325	regulation of phosphorylation	78	1.041865e-1	1.000000e+0	1.000000e+0	9.598174e+0	1.041865e-1	1	1.041865e-1	1.000000e+0	81	1.010747e-1	1.000000e+0	1.000000e+0	9.637286e+0	1.037636e-1	1	936	5.000000e-1	1.068376e-3	unnamed	TPX2
GO Biological Process	GO:0072358	cardiovascular system development	79	1.056924e-1	1.000000e+0	1.000000e+0	9.461416e+0	1.056924e-1	1	1.056924e-1	1.000000e+0	73	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	MYLK2
GO Biological Process	GO:0007049	cell cycle	80	1.078728e-1	1.000000e+0	1.000000e+0	9.270177e+0	1.078728e-1	1	1.078728e-1	1.000000e+0	91	1.322278e-1	1.000000e+0	1.000000e+0	7.304049e+0	1.369104e-1	1	1235	5.000000e-1	8.097166e-4	unnamed	TPX2
GO Biological Process	GO:0009887	organ morphogenesis	81	1.105874e-1	1.000000e+0	1.000000e+0	9.042623e+0	1.105874e-1	1	1.105874e-1	1.000000e+0	74	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	MYLK2
GO Biological Process	GO:0008219	cell death	82	1.161348e-1	1.000000e+0	1.000000e+0	8.610686e+0	1.161348e-1	1	1.161348e-1	1.000000e+0	92	1.323311e-1	1.000000e+0	1.000000e+0	7.298139e+0	1.370212e-1	1	1236	5.000000e-1	8.090615e-4	unnamed	TPX2
GO Biological Process	GO:0016265	death	83	1.165949e-1	1.000000e+0	1.000000e+0	8.576703e+0	1.165949e-1	1	1.165949e-1	1.000000e+0	93	1.326408e-1	1.000000e+0	1.000000e+0	7.280468e+0	1.373538e-1	1	1239	5.000000e-1	8.071025e-4	unnamed	TPX2
GO Biological Process	GO:0031399	regulation of protein modification process	84	1.170270e-1	1.000000e+0	1.000000e+0	8.545037e+0	1.170270e-1	1	1.170270e-1	1.000000e+0	87	1.196868e-1	1.000000e+0	1.000000e+0	8.097397e+0	1.234965e-1	1	1114	5.000000e-1	8.976661e-4	unnamed	TPX2
GO Biological Process	GO:0043085	positive regulation of catalytic activity	85	1.192177e-1	1.000000e+0	1.000000e+0	8.388019e+0	1.192177e-1	1	1.192177e-1	1.000000e+0	88	1.198949e-1	1.000000e+0	1.000000e+0	8.082885e+0	1.237182e-1	1	1116	5.000000e-1	8.960573e-4	unnamed	TPX2
GO Biological Process	GO:0007267	cell-cell signaling	86	1.200910e-1	1.000000e+0	1.000000e+0	8.327020e+0	1.200910e-1	1	1.200910e-1	1.000000e+0	80	9.823445e-2	1.000000e+0	1.000000e+0	9.923542e+0	1.007705e-1	1	909	5.000000e-1	1.100110e-3	unnamed	MYLK2
GO Biological Process	GO:0032268	regulation of cellular protein metabolic process	87	1.389785e-1	1.000000e+0	1.000000e+0	7.195356e+0	1.389785e-1	1	1.389785e-1	1.000000e+0	97	1.498997e-1	1.000000e+0	1.000000e+0	6.411158e+0	1.559780e-1	1	1407	5.000000e-1	7.107321e-4	unnamed	TPX2
GO Biological Process	GO:0051049	regulation of transport	88	1.390239e-1	1.000000e+0	1.000000e+0	7.193009e+0	1.390239e-1	1	1.390239e-1	1.000000e+0	90	1.304713e-1	1.000000e+0	1.000000e+0	7.405993e+0	1.350258e-1	1	1218	5.000000e-1	8.210181e-4	unnamed	MYLK2
GO Biological Process	GO:0044093	positive regulation of molecular function	89	1.422599e-1	1.000000e+0	1.000000e+0	7.029386e+0	1.422599e-1	1	1.422599e-1	1.000000e+0	94	1.401616e-1	1.000000e+0	1.000000e+0	6.875381e+0	1.454465e-1	1	1312	5.000000e-1	7.621951e-4	unnamed	TPX2
GO Biological Process	GO:0010628	positive regulation of gene expression	90	1.480202e-1	1.000000e+0	1.000000e+0	6.755834e+0	1.480202e-1	1	1.480202e-1	1.000000e+0	89	1.249837e-1	1.000000e+0	1.000000e+0	7.742918e+0	1.291503e-1	1	1165	5.000000e-1	8.583691e-4	unnamed	MYLK2
GO Biological Process	GO:0051246	regulation of protein metabolic process	91	1.559232e-1	1.000000e+0	1.000000e+0	6.413414e+0	1.559232e-1	1	1.559232e-1	1.000000e+0	101	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	TPX2
GO Biological Process	GO:0050877	neurological system process	92	1.566250e-1	1.000000e+0	1.000000e+0	6.384679e+0	1.566250e-1	1	1.566250e-1	1.000000e+0	100	1.641497e-1	1.000000e+0	1.000000e+0	5.830963e+0	1.714983e-1	1	1547	5.000000e-1	6.464124e-4	unnamed	MYLK2
GO Biological Process	GO:0051128	regulation of cellular component organization	93	1.583941e-1	1.000000e+0	1.000000e+0	6.313365e+0	1.583941e-1	1	1.583941e-1	1.000000e+0	96	1.493886e-1	1.000000e+0	1.000000e+0	6.434023e+0	1.554238e-1	1	1402	5.000000e-1	7.132668e-4	unnamed	TPX2
GO Biological Process	GO:0019220	regulation of phosphate metabolic process	94	1.631781e-1	1.000000e+0	1.000000e+0	6.128273e+0	1.631781e-1	1	1.631781e-1	1.000000e+0	98	1.538815e-1	1.000000e+0	1.000000e+0	6.238243e+0	1.603015e-1	1	1446	5.000000e-1	6.915629e-4	unnamed	TPX2
GO Biological Process	GO:0051174	regulation of phosphorus metabolic process	95	1.640067e-1	1.000000e+0	1.000000e+0	6.097311e+0	1.640067e-1	1	1.640067e-1	1.000000e+0	99	1.552066e-1	1.000000e+0	1.000000e+0	6.182659e+0	1.617427e-1	1	1459	5.000000e-1	6.854010e-4	unnamed	TPX2
GO Biological Process	GO:0009888	tissue development	96	1.692045e-1	1.000000e+0	1.000000e+0	5.910010e+0	1.692045e-1	1	1.692045e-1	1.000000e+0	95	1.422163e-1	1.000000e+0	1.000000e+0	6.772147e+0	1.476637e-1	1	1332	5.000000e-1	7.507508e-4	unnamed	MYLK2
GO Biological Process	GO:0050790	regulation of catalytic activity	97	1.756788e-1	1.000000e+0	1.000000e+0	5.692208e+0	1.756788e-1	1	1.756788e-1	1.000000e+0	103	1.830959e-1	1.000000e+0	1.000000e+0	5.199135e+0	1.923397e-1	1	1735	5.000000e-1	5.763689e-4	unnamed	TPX2
GO Biological Process	GO:0006796	phosphate-containing compound metabolic process	98	1.861159e-1	1.000000e+0	1.000000e+0	5.372996e+0	1.861159e-1	1	1.861159e-1	1.000000e+0	107	2.116001e-1	1.000000e+0	1.000000e+0	4.461177e+0	2.241561e-1	1	2022	5.000000e-1	4.945598e-4	unnamed	MYLK2
GO Biological Process	GO:0032879	regulation of localization	99	1.871404e-1	1.000000e+0	1.000000e+0	5.343583e+0	1.871404e-1	1	1.871404e-1	1.000000e+0	102	1.713304e-1	1.000000e+0	1.000000e+0	5.575093e+0	1.793692e-1	1	1618	5.000000e-1	6.180470e-4	unnamed	MYLK2
GO Biological Process	GO:0006793	phosphorus metabolic process	100	1.905359e-1	1.000000e+0	1.000000e+0	5.248354e+0	1.905359e-1	1	1.905359e-1	1.000000e+0	109	2.159254e-1	1.000000e+0	1.000000e+0	4.366167e+0	2.290339e-1	1	2066	5.000000e-1	4.840271e-4	unnamed	MYLK2
GO Biological Process	GO:0003008	system process	101	1.967197e-1	1.000000e+0	1.000000e+0	5.083376e+0	1.967197e-1	1	1.967197e-1	1.000000e+0	105	2.046945e-1	1.000000e+0	1.000000e+0	4.621158e+0	2.163960e-1	1	1952	5.000000e-1	5.122951e-4	unnamed	MYLK2
GO Biological Process	GO:0006996	organelle organization	102	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	112	2.321362e-1	1.000000e+0	1.000000e+0	4.041443e+0	2.474364e-1	1	2232	5.000000e-1	4.480287e-4	unnamed	TPX2
GO Biological Process	GO:0006464	cellular protein modification process	103	2.092214e-1	1.000000e+0	1.000000e+0	4.779626e+0	2.092214e-1	1	2.092214e-1	1.000000e+0	111	2.280507e-1	1.000000e+0	1.000000e+0	4.118950e+0	2.427803e-1	1	2190	5.000000e-1	4.566210e-4	unnamed	MYLK2
GO Biological Process	GO:0065009	regulation of molecular function	104	2.156945e-1	1.000000e+0	1.000000e+0	4.636187e+0	2.156945e-1	1	2.156945e-1	1.000000e+0	110	2.197492e-1	1.000000e+0	1.000000e+0	4.285273e+0	2.333574e-1	1	2105	5.000000e-1	4.750594e-4	unnamed	TPX2
GO Biological Process	GO:0043412	macromolecule modification	105	2.160048e-1	1.000000e+0	1.000000e+0	4.629527e+0	2.160048e-1	1	2.160048e-1	1.000000e+0	113	2.399849e-1	1.000000e+0	1.000000e+0	3.899914e+0	2.564159e-1	1	2313	5.000000e-1	4.323390e-4	unnamed	MYLK2
GO Biological Process	GO:0010604	positive regulation of macromolecule metabolic process	106	2.215598e-1	1.000000e+0	1.000000e+0	4.513455e+0	2.215598e-1	1	2.215598e-1	1.000000e+0	20	1.224733e-2	1.000000e+0	1.000000e+0	9.034051e+0	2.213846e-1	2	1997	1.000000e+0	1.001502e-3	unnamed	MYLK2,TPX2
GO Biological Process	GO:0031325	positive regulation of cellular metabolic process	107	2.230682e-1	1.000000e+0	1.000000e+0	4.482934e+0	2.230682e-1	1	2.230682e-1	1.000000e+0	108	2.132726e-1	1.000000e+0	1.000000e+0	4.423982e+0	2.260407e-1	1	2039	5.000000e-1	4.904365e-4	unnamed	TPX2
GO Biological Process	GO:0009893	positive regulation of metabolic process	108	2.357828e-1	1.000000e+0	1.000000e+0	4.241191e+0	2.357828e-1	1	2.357828e-1	1.000000e+0	23	1.423604e-2	1.000000e+0	1.000000e+0	8.379471e+0	2.386786e-1	2	2153	1.000000e+0	9.289364e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0051239	regulation of multicellular organismal process	109	2.372698e-1	1.000000e+0	1.000000e+0	4.214612e+0	2.372698e-1	1	2.372698e-1	1.000000e+0	106	2.076578e-1	1.000000e+0	1.000000e+0	4.551211e+0	2.197217e-1	1	1982	5.000000e-1	5.045409e-4	unnamed	MYLK2
GO Biological Process	GO:0009653	anatomical structure morphogenesis	110	2.467616e-1	1.000000e+0	1.000000e+0	4.052494e+0	2.467616e-1	1	2.467616e-1	1.000000e+0	104	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	MYLK2
GO Biological Process	GO:0044267	cellular protein metabolic process	111	2.533433e-1	1.000000e+0	1.000000e+0	3.947214e+0	2.533433e-1	1	2.533433e-1	1.000000e+0	120	2.989111e-1	1.000000e+0	1.000000e+0	3.073424e+0	3.253700e-1	1	2935	5.000000e-1	3.407155e-4	unnamed	MYLK2
GO Biological Process	GO:0048513	organ development	112	2.824258e-1	1.000000e+0	1.000000e+0	3.540753e+0	2.824258e-1	1	2.824258e-1	1.000000e+0	115	2.446169e-1	1.000000e+0	1.000000e+0	3.820627e+0	2.617372e-1	1	2361	5.000000e-1	4.235493e-4	unnamed	MYLK2
GO Biological Process	GO:0019538	protein metabolic process	113	2.975455e-1	1.000000e+0	1.000000e+0	3.360830e+0	2.975455e-1	1	2.975455e-1	1.000000e+0	125	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	MYLK2
GO Biological Process	GO:0030154	cell differentiation	114	3.160741e-1	1.000000e+0	1.000000e+0	3.163815e+0	3.160741e-1	1	3.160741e-1	1.000000e+0	117	2.690819e-1	1.000000e+0	1.000000e+0	3.446886e+0	2.901170e-1	1	2617	5.000000e-1	3.821169e-4	unnamed	MYLK2
GO Biological Process	GO:0048869	cellular developmental process	115	3.225257e-1	1.000000e+0	1.000000e+0	3.100528e+0	3.225257e-1	1	3.225257e-1	1.000000e+0	118	2.802231e-1	1.000000e+0	1.000000e+0	3.298172e+0	3.031983e-1	1	2735	5.000000e-1	3.656307e-4	unnamed	MYLK2
GO Biological Process	GO:0048522	positive regulation of cellular process	116	3.411192e-1	1.000000e+0	1.000000e+0	2.931526e+0	3.411192e-1	1	3.411192e-1	1.000000e+0	122	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	TPX2
GO Biological Process	GO:0010468	regulation of gene expression	117	3.434880e-1	1.000000e+0	1.000000e+0	2.911310e+0	3.434880e-1	1	3.434880e-1	1.000000e+0	126	3.723475e-1	1.000000e+0	1.000000e+0	2.406750e+0	4.154980e-1	1	3748	5.000000e-1	2.668090e-4	unnamed	MYLK2
GO Biological Process	GO:0048518	positive regulation of biological process	118	3.729968e-1	1.000000e+0	1.000000e+0	2.680988e+0	3.729968e-1	1	3.729968e-1	1.000000e+0	46	4.225707e-2	1.000000e+0	1.000000e+0	4.864114e+0	4.111745e-1	2	3709	1.000000e+0	5.392289e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0044767	single-organism developmental process	119	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	122	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	MYLK2
GO Biological Process	GO:0016043	cellular component organization	120	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	130	3.965267e-1	1.000000e+0	1.000000e+0	2.240561e+0	4.463167e-1	1	4026	5.000000e-1	2.483855e-4	unnamed	TPX2
GO Biological Process	GO:0071840	cellular component organization or biogenesis	121	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	131	4.070731e-1	1.000000e+0	1.000000e+0	2.174138e+0	4.599523e-1	1	4149	5.000000e-1	2.410219e-4	unnamed	TPX2
GO Biological Process	GO:0048731	system development	122	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	124	3.405107e-1	1.000000e+0	1.000000e+0	2.660914e+0	3.758107e-1	1	3390	5.000000e-1	2.949853e-4	unnamed	MYLK2
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	123	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	62	6.596616e-2	1.000000e+0	1.000000e+0	3.893181e+0	5.137188e-1	2	4634	1.000000e+0	4.315926e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0048856	anatomical structure development	124	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	128	3.845834e-1	1.000000e+0	1.000000e+0	2.320087e+0	4.310182e-1	1	3888	5.000000e-1	2.572016e-4	unnamed	MYLK2
GO Biological Process	GO:0007275	multicellular organismal development	125	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	129	3.919536e-1	1.000000e+0	1.000000e+0	2.270451e+0	4.404412e-1	1	3973	5.000000e-1	2.516990e-4	unnamed	MYLK2
GO Biological Process	GO:0080090	regulation of primary metabolic process	126	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	135	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	TPX2
GO Biological Process	GO:0044700	single organism signaling	127	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	133	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	MYLK2
GO Biological Process	GO:0031323	regulation of cellular metabolic process	128	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	136	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	TPX2
GO Biological Process	GO:0007154	cell communication	129	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	134	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	MYLK2
GO Biological Process	GO:0032502	developmental process	130	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	132	4.306509e-1	1.000000e+0	1.000000e+0	2.037150e+0	4.908819e-1	1	4428	5.000000e-1	2.258356e-4	unnamed	MYLK2
GO Biological Process	GO:0019222	regulation of metabolic process	131	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	77	9.333456e-2	1.000000e+0	1.000000e+0	3.273041e+0	6.110526e-1	2	5512	1.000000e+0	3.628447e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	132	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	140	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	MYLK2
GO Biological Process	GO:0043170	macromolecule metabolic process	133	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	141	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	MYLK2
GO Biological Process	GO:0044707	single-multicellular organism process	134	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	137	5.291973e-1	1.000000e+0	1.000000e+0	1.593165e+0	6.276814e-1	1	5662	5.000000e-1	1.766160e-4	unnamed	MYLK2
GO Biological Process	GO:0032501	multicellular organismal process	135	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	138	5.461571e-1	1.000000e+0	1.000000e+0	1.532275e+0	6.526246e-1	1	5887	5.000000e-1	1.698658e-4	unnamed	MYLK2
GO Biological Process	GO:0044237	cellular metabolic process	136	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	142	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	MYLK2
GO Biological Process	GO:0044238	primary metabolic process	137	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	143	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	MYLK2
GO Biological Process	GO:0071704	organic substance metabolic process	138	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	144	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	MYLK2
GO Biological Process	GO:0008152	metabolic process	139	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	145	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	MYLK2
GO Biological Process	GO:0050794	regulation of cellular process	140	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	114	2.408423e-1	1.000000e+0	1.000000e+0	2.037610e+0	9.815420e-1	2	8854	1.000000e+0	2.258866e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0050789	regulation of biological process	141	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	116	2.673785e-1	1.000000e+0	1.000000e+0	1.933862e+0	1.034200e+0	2	9329	1.000000e+0	2.143853e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0065007	biological regulation	142	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	119	2.982605e-1	1.000000e+0	1.000000e+0	1.831016e+0	1.092290e+0	2	9853	1.000000e+0	2.029839e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0044763	single-organism cellular process	143	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	121	3.141478e-1	1.000000e+0	1.000000e+0	1.784118e+0	1.121002e+0	2	10112	1.000000e+0	1.977848e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0044699	single-organism process	144	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	127	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	MYLK2,TPX2
GO Biological Process	GO:0009987	cellular process	145	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	139	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0000922	spindle pole	1	9.779420e-3	1.000000e+0	1.000000e+0	1.022556e+2	9.779420e-3	1	9.779420e-3	1.000000e+0	1	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	TPX2
GO Cellular Component	GO:0030017	sarcomere	2	1.887048e-2	1.000000e+0	1.000000e+0	5.299283e+1	1.887048e-2	1	1.887048e-2	1.000000e+0	2	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	MYLK2
GO Cellular Component	GO:0044449	contractile fiber part	3	2.023967e-2	1.000000e+0	1.000000e+0	4.940792e+1	2.023967e-2	1	2.023967e-2	1.000000e+0	3	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	MYLK2
GO Cellular Component	GO:0030016	myofibril	4	2.078730e-2	1.000000e+0	1.000000e+0	4.810630e+1	2.078730e-2	1	2.078730e-2	1.000000e+0	4	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	MYLK2
GO Cellular Component	GO:0043292	contractile fiber	5	2.185705e-2	1.000000e+0	1.000000e+0	4.575183e+1	2.185705e-2	1	2.185705e-2	1.000000e+0	5	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MYLK2
GO Cellular Component	GO:0005819	spindle	6	2.347518e-2	1.000000e+0	1.000000e+0	4.259817e+1	2.347518e-2	1	2.347518e-2	1.000000e+0	6	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	TPX2
GO Cellular Component	GO:0005874	microtubule	7	3.699143e-2	1.000000e+0	1.000000e+0	2.703329e+1	3.699143e-2	1	3.699143e-2	1.000000e+0	8	4.048959e-2	1.000000e+0	1.000000e+0	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	TPX2
GO Cellular Component	GO:0015630	microtubule cytoskeleton	8	8.547273e-2	1.000000e+0	1.000000e+0	1.169964e+1	8.547273e-2	1	8.547273e-2	1.000000e+0	9	1.006542e-1	1.000000e+0	1.000000e+0	9.678648e+0	1.033202e-1	1	932	5.000000e-1	1.072961e-3	unnamed	TPX2
GO Cellular Component	GO:0044430	cytoskeletal part	9	1.208518e-1	1.000000e+0	1.000000e+0	8.274597e+0	1.208518e-1	1	1.208518e-1	1.000000e+0	12	1.458062e-1	1.000000e+0	1.000000e+0	6.598756e+0	1.515437e-1	1	1367	5.000000e-1	7.315289e-4	unnamed	TPX2
GO Cellular Component	GO:0005856	cytoskeleton	10	1.730861e-1	1.000000e+0	1.000000e+0	5.777472e+0	1.730861e-1	1	1.730861e-1	1.000000e+0	13	1.976595e-1	1.000000e+0	1.000000e+0	4.795587e+0	2.085250e-1	1	1881	5.000000e-1	5.316321e-4	unnamed	TPX2
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	11	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	7	3.399992e-2	1.000000e+0	1.000000e+0	5.422603e+0	3.688266e-1	2	3327	1.000000e+0	6.011422e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0043234	protein complex	12	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	17	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	TPX2
GO Cellular Component	GO:0032991	macromolecular complex	13	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	20	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	TPX2
GO Cellular Component	GO:0044446	intracellular organelle part	14	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	23	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	TPX2
GO Cellular Component	GO:0005634	nucleus	15	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	10	1.133394e-1	1.000000e+0	1.000000e+0	2.970201e+0	6.733551e-1	2	6074	1.000000e+0	3.292723e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0044422	organelle part	16	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	11	1.337401e-1	1.000000e+0	1.000000e+0	2.734313e+0	7.314450e-1	2	6598	1.000000e+0	3.031222e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0044444	cytoplasmic part	17	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	24	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	MYLK2
GO Cellular Component	GO:0005737	cytoplasm	18	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	14	2.746502e-1	1.000000e+0	1.000000e+0	1.908091e+0	1.048168e+0	2	9455	1.000000e+0	2.115283e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	19	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	15	3.079649e-1	1.000000e+0	1.000000e+0	1.801938e+0	1.109916e+0	2	10012	1.000000e+0	1.997603e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0043227	membrane-bounded organelle	20	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	16	3.100602e-1	1.000000e+0	1.000000e+0	1.795839e+0	1.113685e+0	2	10046	1.000000e+0	1.990842e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0043229	intracellular organelle	21	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	18	3.712075e-1	1.000000e+0	1.000000e+0	1.641285e+0	1.218558e+0	2	10992	1.000000e+0	1.819505e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0043226	organelle	22	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	19	3.733721e-1	1.000000e+0	1.000000e+0	1.636520e+0	1.222105e+0	2	11024	1.000000e+0	1.814224e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0044424	intracellular part	23	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	21	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0005622	intracellular	24	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	22	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0044464	cell part	25	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	25	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	MYLK2,TPX2
GO Cellular Component	GO:0005623	cell	26	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	26	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	MYLK2,TPX2
Mouse Phenotype	MP:0008371	pituitary intermediate lobe hyperplasia	1	2.744988e-4	1.000000e+0	1.000000e+0	3.643003e+3	2.744988e-4	1	2.744988e-4	1.000000e+0	1	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	TPX2
Mouse Phenotype	MP:0009762	abnormal mitotic spindle assembly checkpoint	2	8.504348e-4	1.000000e+0	1.000000e+0	1.175869e+3	8.504348e-4	1	8.504348e-4	1.000000e+0	2	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	TPX2
Mouse Phenotype	MP:0008130	abnormal pituitary intermediate lobe morphology	3	1.675449e-3	1.000000e+0	1.000000e+0	5.968548e+2	1.675449e-3	1	1.675449e-3	1.000000e+0	3	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	TPX2
Mouse Phenotype	MP:0004025	polyploidy	4	1.763393e-3	1.000000e+0	1.000000e+0	5.670885e+2	1.763393e-3	1	1.763393e-3	1.000000e+0	5	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	TPX2
Mouse Phenotype	MP:0010301	increased stomach tumor incidence	5	1.765417e-3	1.000000e+0	1.000000e+0	5.664385e+2	1.765417e-3	1	1.765417e-3	1.000000e+0	4	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	TPX2
Mouse Phenotype	MP:0002841	impaired skeletal muscle contractility	6	2.703458e-3	1.000000e+0	1.000000e+0	3.698967e+2	2.703458e-3	1	2.703458e-3	1.000000e+0	7	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	MYLK2
Mouse Phenotype	MP:0002500	granulomatous inflammation	7	2.912248e-3	1.000000e+0	1.000000e+0	3.433774e+2	2.912248e-3	1	2.912248e-3	1.000000e+0	7	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	TPX2
Mouse Phenotype	MP:0009760	abnormal mitotic spindle morphology	8	3.608524e-3	1.000000e+0	1.000000e+0	2.771216e+2	3.608524e-3	1	3.608524e-3	1.000000e+0	6	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	TPX2
Mouse Phenotype	MP:0004045	abnormal cell cycle checkpoint function	9	4.183364e-3	1.000000e+0	1.000000e+0	2.390421e+2	4.183364e-3	1	4.183364e-3	1.000000e+0	12	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	TPX2
Mouse Phenotype	MP:0002048	increased lung adenoma incidence	10	4.364080e-3	1.000000e+0	1.000000e+0	2.291433e+2	4.364080e-3	1	4.364080e-3	1.000000e+0	10	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	TPX2
Mouse Phenotype	MP:0004024	aneuploidy	11	4.788014e-3	1.000000e+0	1.000000e+0	2.088548e+2	4.788014e-3	1	4.788014e-3	1.000000e+0	10	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	TPX2
Mouse Phenotype	MP:0002499	chronic inflammation	12	5.077761e-3	1.000000e+0	1.000000e+0	1.969372e+2	5.077761e-3	1	5.077761e-3	1.000000e+0	14	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	TPX2
Mouse Phenotype	MP:0002404	increased intestinal adenoma incidence	13	5.229360e-3	1.000000e+0	1.000000e+0	1.912280e+2	5.229360e-3	1	5.229360e-3	1.000000e+0	9	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	TPX2
Mouse Phenotype	MP:0009332	abnormal splenocyte morphology	14	5.771097e-3	1.000000e+0	1.000000e+0	1.732773e+2	5.771097e-3	1	5.771097e-3	1.000000e+0	13	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	TPX2
Mouse Phenotype	MP:0004023	abnormal chromosome number	15	5.908002e-3	1.000000e+0	1.000000e+0	1.692619e+2	5.908002e-3	1	5.908002e-3	1.000000e+0	17	7.745261e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	70	5.000000e-1	1.428571e-2	unnamed	TPX2
Mouse Phenotype	MP:0002027	lung adenocarcinoma	16	6.674635e-3	1.000000e+0	1.000000e+0	1.498209e+2	6.674635e-3	1	6.674635e-3	1.000000e+0	16	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	TPX2
Mouse Phenotype	MP:0008716	lung non-small cell carcinoma	17	7.123287e-3	1.000000e+0	1.000000e+0	1.403846e+2	7.123287e-3	1	7.123287e-3	1.000000e+0	19	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	TPX2
Mouse Phenotype	MP:0001272	increased metastatic potential	18	7.760129e-3	1.000000e+0	1.000000e+0	1.288638e+2	7.760129e-3	1	7.760129e-3	1.000000e+0	14	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	TPX2
Mouse Phenotype	MP:0003331	hepatocellular carcinoma	19	7.844842e-3	1.000000e+0	1.000000e+0	1.274723e+2	7.844842e-3	1	7.844842e-3	1.000000e+0	18	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	TPX2
Mouse Phenotype	MP:0008714	lung carcinoma	20	8.130735e-3	1.000000e+0	1.000000e+0	1.229901e+2	8.130735e-3	1	8.130735e-3	1.000000e+0	20	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	TPX2
Mouse Phenotype	MP:0010279	increased gastrointestinal tumor incidence	21	9.719407e-3	1.000000e+0	1.000000e+0	1.028869e+2	9.719407e-3	1	9.719407e-3	1.000000e+0	21	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	TPX2
Mouse Phenotype	MP:0010292	increased alimentary system tumor incidence	22	1.051172e-2	1.000000e+0	1.000000e+0	9.513187e+1	1.051172e-2	1	1.051172e-2	1.000000e+0	25	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	TPX2
Mouse Phenotype	MP:0004046	abnormal mitosis	23	1.141663e-2	1.000000e+0	1.000000e+0	8.759154e+1	1.141663e-2	1	1.141663e-2	1.000000e+0	23	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	TPX2
Mouse Phenotype	MP:0008019	increased liver tumor incidence	24	1.160410e-2	1.000000e+0	1.000000e+0	8.617647e+1	1.160410e-2	1	1.160410e-2	1.000000e+0	22	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	TPX2
Mouse Phenotype	MP:0010297	increased hepatobiliary system tumor incidence	25	1.173767e-2	1.000000e+0	1.000000e+0	8.519581e+1	1.173767e-2	1	1.173767e-2	1.000000e+0	25	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	TPX2
Mouse Phenotype	MP:0000858	altered metastatic potential	26	1.292605e-2	1.000000e+0	1.000000e+0	7.736317e+1	1.292605e-2	1	1.292605e-2	1.000000e+0	23	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	TPX2
Mouse Phenotype	MP:0008014	increased lung tumor incidence	27	1.298326e-2	1.000000e+0	1.000000e+0	7.702228e+1	1.298326e-2	1	1.298326e-2	1.000000e+0	28	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	TPX2
Mouse Phenotype	MP:0003111	abnormal cell nucleus morphology	28	1.402786e-2	1.000000e+0	1.000000e+0	7.128670e+1	1.402786e-2	1	1.402786e-2	1.000000e+0	30	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	TPX2
Mouse Phenotype	MP:0009308	adenocarcinoma	29	1.492238e-2	1.000000e+0	1.000000e+0	6.701344e+1	1.492238e-2	1	1.492238e-2	1.000000e+0	31	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	TPX2
Mouse Phenotype	MP:0010383	increased adenoma incidence	30	1.689252e-2	1.000000e+0	1.000000e+0	5.919779e+1	1.689252e-2	1	1.689252e-2	1.000000e+0	32	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	TPX2
Mouse Phenotype	MP:0000633	abnormal pituitary gland morphology	31	1.943676e-2	1.000000e+0	1.000000e+0	5.144891e+1	1.943676e-2	1	1.943676e-2	1.000000e+0	27	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	TPX2
Mouse Phenotype	MP:0002022	increased lymphoma incidence	32	2.227473e-2	1.000000e+0	1.000000e+0	4.489392e+1	2.227473e-2	1	2.227473e-2	1.000000e+0	33	2.413134e-2	1.000000e+0	1.000000e+0	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	TPX2
Mouse Phenotype	MP:0000631	abnormal neuroendocrine gland morphology	33	2.257618e-2	1.000000e+0	1.000000e+0	4.429447e+1	2.257618e-2	1	2.257618e-2	1.000000e+0	29	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	TPX2
Mouse Phenotype	MP:0003077	abnormal cell cycle	34	2.376361e-2	1.000000e+0	1.000000e+0	4.208115e+1	2.376361e-2	1	2.376361e-2	1.000000e+0	35	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	TPX2
Mouse Phenotype	MP:0010639	altered tumor pathology	35	2.612052e-2	1.000000e+0	1.000000e+0	3.828408e+1	2.612052e-2	1	2.612052e-2	1.000000e+0	34	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	TPX2
Mouse Phenotype	MP:0010296	increased hemolymphoid system tumor incidence	36	2.613114e-2	1.000000e+0	1.000000e+0	3.826852e+1	2.613114e-2	1	2.613114e-2	1.000000e+0	35	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	TPX2
Mouse Phenotype	MP:0002038	carcinoma	37	2.714825e-2	1.000000e+0	1.000000e+0	3.683478e+1	2.714825e-2	1	2.714825e-2	1.000000e+0	38	2.970866e-2	1.000000e+0	1.000000e+0	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	TPX2
Mouse Phenotype	MP:0001730	embryonic growth arrest	38	3.128215e-2	1.000000e+0	1.000000e+0	3.196712e+1	3.128215e-2	1	3.128215e-2	1.000000e+0	40	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	TPX2
Mouse Phenotype	MP:0002018	malignant tumors	39	3.474739e-2	1.000000e+0	1.000000e+0	2.877914e+1	3.474739e-2	1	3.474739e-2	1.000000e+0	41	3.646740e-2	1.000000e+0	1.000000e+0	2.717018e+1	3.680506e-2	1	332	5.000000e-1	3.012048e-3	unnamed	TPX2
Mouse Phenotype	MP:0000738	impaired muscle contractility	40	3.540346e-2	1.000000e+0	1.000000e+0	2.824583e+1	3.540346e-2	1	3.540346e-2	1.000000e+0	37	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	MYLK2
Mouse Phenotype	MP:0000358	abnormal cell morphology	41	3.732183e-2	1.000000e+0	1.000000e+0	2.679397e+1	3.732183e-2	1	3.732183e-2	1.000000e+0	44	4.385306e-2	1.000000e+0	1.000000e+0	2.255125e+1	4.434344e-2	1	400	5.000000e-1	2.500000e-3	unnamed	TPX2
Mouse Phenotype	MP:0000830	abnormal diencephalon morphology	42	4.253763e-2	1.000000e+0	1.000000e+0	2.350860e+1	4.253763e-2	1	4.253763e-2	1.000000e+0	39	3.025460e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	275	5.000000e-1	3.636364e-3	unnamed	TPX2
Mouse Phenotype	MP:0011092	complete embryonic lethality	43	4.260939e-2	1.000000e+0	1.000000e+0	2.346900e+1	4.260939e-2	1	4.260939e-2	1.000000e+0	43	3.842519e-2	1.000000e+0	1.000000e+0	2.577286e+1	3.880051e-2	1	350	5.000000e-1	2.857143e-3	unnamed	TPX2
Mouse Phenotype	MP:0005620	abnormal muscle contractility	44	4.427201e-2	1.000000e+0	1.000000e+0	2.258763e+1	4.427201e-2	1	4.427201e-2	1.000000e+0	42	3.722900e-2	1.000000e+0	1.000000e+0	2.660914e+1	3.758107e-2	1	339	5.000000e-1	2.949853e-3	unnamed	MYLK2
Mouse Phenotype	MP:0000352	decreased cell proliferation	45	4.619465e-2	1.000000e+0	1.000000e+0	2.164753e+1	4.619465e-2	1	4.619465e-2	1.000000e+0	45	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	TPX2
Mouse Phenotype	MP:0010273	increased classified tumor incidence	46	5.452900e-2	1.000000e+0	1.000000e+0	1.833887e+1	5.452900e-2	1	5.452900e-2	1.000000e+0	46	5.563254e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	509	5.000000e-1	1.964637e-3	unnamed	TPX2
Mouse Phenotype	MP:0010274	increased organ/body region tumor incidence	47	5.980108e-2	1.000000e+0	1.000000e+0	1.672211e+1	5.980108e-2	1	5.980108e-2	1.000000e+0	47	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	TPX2
Mouse Phenotype	MP:0002020	increased tumor incidence	48	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	48	6.873033e-2	1.000000e+0	1.000000e+0	1.429556e+1	6.995178e-2	1	631	5.000000e-1	1.584786e-3	unnamed	TPX2
Mouse Phenotype	MP:0002019	abnormal tumor incidence	49	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	49	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	TPX2
Mouse Phenotype	MP:0002166	altered tumor susceptibility	50	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	50	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	TPX2
Mouse Phenotype	MP:0000689	abnormal spleen morphology	51	8.333506e-2	1.000000e+0	1.000000e+0	1.199975e+1	8.333506e-2	1	8.333506e-2	1.000000e+0	53	8.979273e-2	1.000000e+0	1.000000e+0	1.088118e+1	9.190178e-2	1	829	5.000000e-1	1.206273e-3	unnamed	TPX2
Mouse Phenotype	MP:0002006	tumorigenesis	52	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	51	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	TPX2
Mouse Phenotype	MP:0000350	abnormal cell proliferation	53	9.545087e-2	1.000000e+0	1.000000e+0	1.047659e+1	9.545087e-2	1	9.545087e-2	1.000000e+0	54	9.021575e-2	1.000000e+0	1.000000e+0	1.082893e+1	9.234521e-2	1	833	5.000000e-1	1.200480e-3	unnamed	TPX2
Mouse Phenotype	MP:0002106	abnormal muscle physiology	54	9.999719e-2	1.000000e+0	1.000000e+0	1.000028e+1	9.999719e-2	1	9.999719e-2	1.000000e+0	52	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	MYLK2
Mouse Phenotype	MP:0001845	abnormal inflammatory response	55	1.012612e-1	1.000000e+0	1.000000e+0	9.875447e+0	1.012612e-1	1	1.012612e-1	1.000000e+0	56	1.166678e-1	1.000000e+0	1.000000e+0	8.313825e+0	1.202816e-1	1	1085	5.000000e-1	9.216590e-4	unnamed	TPX2
Mouse Phenotype	MP:0002722	abnormal immune system organ morphology	56	1.102968e-1	1.000000e+0	1.000000e+0	9.066446e+0	1.102968e-1	1	1.102968e-1	1.000000e+0	57	1.202068e-1	1.000000e+0	1.000000e+0	8.061215e+0	1.240508e-1	1	1119	5.000000e-1	8.936550e-4	unnamed	TPX2
Mouse Phenotype	MP:0000783	abnormal forebrain morphology	57	1.250634e-1	1.000000e+0	1.000000e+0	7.995943e+0	1.250634e-1	1	1.250634e-1	1.000000e+0	55	9.465152e-2	1.000000e+0	1.000000e+0	1.030914e+1	9.700127e-2	1	875	5.000000e-1	1.142857e-3	unnamed	TPX2
Mouse Phenotype	MP:0005369	muscle phenotype	58	1.492399e-1	1.000000e+0	1.000000e+0	6.700621e+0	1.492399e-1	1	1.492399e-1	1.000000e+0	58	1.300577e-1	1.000000e+0	1.000000e+0	7.430395e+0	1.345823e-1	1	1214	5.000000e-1	8.237232e-4	unnamed	MYLK2
Mouse Phenotype	MP:0002163	abnormal gland morphology	59	1.548620e-1	1.000000e+0	1.000000e+0	6.457362e+0	1.548620e-1	1	1.548620e-1	1.000000e+0	59	1.460111e-1	1.000000e+0	1.000000e+0	6.589116e+0	1.517654e-1	1	1369	5.000000e-1	7.304602e-4	unnamed	TPX2
Mouse Phenotype	MP:0008762	embryonic lethality	60	1.587123e-1	1.000000e+0	1.000000e+0	6.300711e+0	1.587123e-1	1	1.587123e-1	1.000000e+0	63	1.667828e-1	1.000000e+0	1.000000e+0	5.734584e+0	1.743806e-1	1	1573	5.000000e-1	6.357279e-4	unnamed	TPX2
Mouse Phenotype	MP:0005379	endocrine/exocrine gland phenotype	61	1.670185e-1	1.000000e+0	1.000000e+0	5.987362e+0	1.670185e-1	1	1.670185e-1	1.000000e+0	61	1.601922e-1	1.000000e+0	1.000000e+0	5.981764e+0	1.671748e-1	1	1508	5.000000e-1	6.631300e-4	unnamed	TPX2
Mouse Phenotype	MP:0001672	abnormal embryogenesis/ development	62	1.759787e-1	1.000000e+0	1.000000e+0	5.682507e+0	1.759787e-1	1	1.759787e-1	1.000000e+0	62	1.649603e-1	1.000000e+0	1.000000e+0	5.800965e+0	1.723851e-1	1	1555	5.000000e-1	6.430868e-4	unnamed	TPX2
Mouse Phenotype	MP:0000685	abnormal immune system morphology	63	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	65	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	TPX2
Mouse Phenotype	MP:0002152	abnormal brain morphology	64	1.867872e-1	1.000000e+0	1.000000e+0	5.353687e+0	1.867872e-1	1	1.867872e-1	1.000000e+0	60	1.513302e-1	1.000000e+0	1.000000e+0	6.347994e+0	1.575301e-1	1	1421	5.000000e-1	7.037298e-4	unnamed	TPX2
Mouse Phenotype	MP:0001790	abnormal immune system physiology	65	1.911135e-1	1.000000e+0	1.000000e+0	5.232494e+0	1.911135e-1	1	1.911135e-1	1.000000e+0	67	2.153363e-1	1.000000e+0	1.000000e+0	4.378883e+0	2.283687e-1	1	2060	5.000000e-1	4.854369e-4	unnamed	TPX2
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	66	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	68	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	TPX2
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	67	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	69	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	TPX2
Mouse Phenotype	MP:0002080	prenatal lethality	68	2.134127e-1	1.000000e+0	1.000000e+0	4.685758e+0	2.134127e-1	1	2.134127e-1	1.000000e+0	66	2.134693e-1	1.000000e+0	1.000000e+0	4.419647e+0	2.262624e-1	1	2041	5.000000e-1	4.899559e-4	unnamed	TPX2
Mouse Phenotype	MP:0005387	immune system phenotype	69	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	71	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	TPX2
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	70	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	70	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	TPX2
Mouse Phenotype	MP:0005621	abnormal cell physiology	71	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	73	3.046545e-1	1.000000e+0	1.000000e+0	3.009843e+0	3.322432e-1	1	2997	5.000000e-1	3.336670e-4	unnamed	TPX2
Mouse Phenotype	MP:0005384	cellular phenotype	72	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	74	3.123982e-1	1.000000e+0	1.000000e+0	2.927783e+0	3.415553e-1	1	3081	5.000000e-1	3.245699e-4	unnamed	TPX2
Mouse Phenotype	MP:0003631	nervous system phenotype	73	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	72	2.844493e-1	1.000000e+0	1.000000e+0	3.244784e+0	3.081869e-1	1	2780	5.000000e-1	3.597122e-4	unnamed	TPX2
Mouse Phenotype	MP:0010770	preweaning lethality	74	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	75	3.286641e-1	1.000000e+0	1.000000e+0	2.767874e+0	3.612882e-1	1	3259	5.000000e-1	3.068426e-4	unnamed	TPX2
Mouse Phenotype	MP:0010769	abnormal survival	75	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	76	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	TPX2
Mouse Phenotype	MP:0010768	mortality/aging	76	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	77	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	TPX2
Mouse Phenotype	MP:0000001	mammalian phenotype	77	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	64	1.739173e-1	1.000000e+0	1.000000e+0	2.397794e+0	8.341001e-1	2	7524	1.000000e+0	2.658161e-4	unnamed	MYLK2,TPX2
Human Phenotype	HP:0001670	Asymmetric septal hypertrophy	1	8.198744e-4	1.000000e+0	1.000000e+0	1.219699e+3	8.198744e-4	1	8.198744e-4	1.000000e+0	2	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MYLK2
Human Phenotype	HP:0001682	Subvalvular aortic stenosis	2	9.668142e-4	1.000000e+0	1.000000e+0	1.034325e+3	9.668142e-4	1	9.668142e-4	1.000000e+0	1	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	MYLK2
Human Phenotype	HP:0001699	Sudden death	3	1.657789e-3	1.000000e+0	1.000000e+0	6.032130e+2	1.657789e-3	1	1.657789e-3	1.000000e+0	3	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	MYLK2
Human Phenotype	HP:0001711	Abnormality of the left ventricle	4	5.244638e-3	1.000000e+0	1.000000e+0	1.906709e+2	5.244638e-3	1	5.244638e-3	1.000000e+0	4	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	MYLK2
Human Phenotype	HP:0001635	Congestive heart failure	5	9.050497e-3	1.000000e+0	1.000000e+0	1.104912e+2	9.050497e-3	1	9.050497e-3	1.000000e+0	5	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	MYLK2
Human Phenotype	HP:0011420	Death	6	9.137976e-3	1.000000e+0	1.000000e+0	1.094334e+2	9.137976e-3	1	9.137976e-3	1.000000e+0	6	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	MYLK2
Human Phenotype	HP:0001639	Hypertrophic cardiomyopathy	7	1.549127e-2	1.000000e+0	1.000000e+0	6.455250e+1	1.549127e-2	1	1.549127e-2	1.000000e+0	7	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	MYLK2
Human Phenotype	HP:0001638	Cardiomyopathy	8	2.024024e-2	1.000000e+0	1.000000e+0	4.940652e+1	2.024024e-2	1	2.024024e-2	1.000000e+0	10	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	MYLK2
Human Phenotype	HP:0001637	Abnormality of the myocardium	9	2.048425e-2	1.000000e+0	1.000000e+0	4.881799e+1	2.048425e-2	1	2.048425e-2	1.000000e+0	11	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	MYLK2
Human Phenotype	HP:0011675	Arrhythmia	10	2.164317e-2	1.000000e+0	1.000000e+0	4.620396e+1	2.164317e-2	1	2.164317e-2	1.000000e+0	9	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	MYLK2
Human Phenotype	HP:0001713	Abnormality of cardiac ventricle	11	2.770630e-2	1.000000e+0	1.000000e+0	3.609287e+1	2.770630e-2	1	2.770630e-2	1.000000e+0	8	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	MYLK2
Human Phenotype	HP:0011025	Abnormality of cardiovascular system physiology	12	4.649297e-2	1.000000e+0	1.000000e+0	2.150863e+1	4.649297e-2	1	4.649297e-2	1.000000e+0	12	4.958982e-2	1.000000e+0	1.000000e+0	1.991280e+1	5.021895e-2	1	453	5.000000e-1	2.207506e-3	unnamed	MYLK2
Human Phenotype	HP:0002564	Malformation of the heart and great vessels	13	7.308175e-2	1.000000e+0	1.000000e+0	1.368331e+1	7.308175e-2	1	7.308175e-2	1.000000e+0	13	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	MYLK2
Human Phenotype	HP:0001627	Abnormality of the heart	14	7.369587e-2	1.000000e+0	1.000000e+0	1.356928e+1	7.369587e-2	1	7.369587e-2	1.000000e+0	14	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	MYLK2
Human Phenotype	HP:0000004	Onset and clinical course	15	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	15	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	MYLK2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	16	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	16	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	MYLK2
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	17	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	18	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	MYLK2
Human Phenotype	HP:0000006	Autosomal dominant inheritance	18	1.208130e-1	1.000000e+0	1.000000e+0	8.277255e+0	1.208130e-1	1	1.208130e-1	1.000000e+0	17	1.191667e-1	1.000000e+0	1.000000e+0	8.133904e+0	1.229422e-1	1	1109	5.000000e-1	9.017133e-4	unnamed	MYLK2
Human Phenotype	HP:0000005	Mode of inheritance	19	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	19	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	MYLK2
Human Phenotype	HP:0000118	Phenotypic abnormality	20	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	20	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	MYLK2
Human Phenotype	HP:0000001	All	21	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	21	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	MYLK2
Disease Ontology	DOID:3069	astrocytoma	1	4.313016e-2	1.000000e+0	1.000000e+0	2.318563e+1	4.313016e-2	1	4.313016e-2	1.000000e+0	1	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	TPX2
Disease Ontology	DOID:2126	primary brain tumor	2	4.334785e-2	1.000000e+0	1.000000e+0	2.306920e+1	4.334785e-2	1	4.334785e-2	1.000000e+0	2	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	TPX2
Disease Ontology	DOID:911	malignant neoplasm of brain	3	4.364353e-2	1.000000e+0	1.000000e+0	2.291290e+1	4.364353e-2	1	4.364353e-2	1.000000e+0	3	4.222631e-2	1.000000e+0	1.000000e+0	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	TPX2
Disease Ontology	DOID:368	neoplasm of cerebrum	4	4.511970e-2	1.000000e+0	1.000000e+0	2.216327e+1	4.511970e-2	1	4.511970e-2	1.000000e+0	4	4.298563e-2	1.000000e+0	1.000000e+0	2.301148e+1	4.345657e-2	1	392	5.000000e-1	2.551020e-3	unnamed	TPX2
Disease Ontology	DOID:1659	supratentorial neoplasm	5	4.529725e-2	1.000000e+0	1.000000e+0	2.207640e+1	4.529725e-2	1	4.529725e-2	1.000000e+0	5	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	TPX2
Disease Ontology	DOID:449	head neoplasm	6	5.090150e-2	1.000000e+0	1.000000e+0	1.964579e+1	5.090150e-2	1	5.090150e-2	1.000000e+0	6	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	TPX2
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	7	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	8	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	TPX2
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	8	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	9	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	TPX2
Disease Ontology	DOID:3070	malignant glioma	9	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	10	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	TPX2
Disease Ontology	DOID:2627	glioma	10	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	11	1.084173e-1	1.000000e+0	1.000000e+0	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	TPX2
Disease Ontology	DOID:1319	brain neoplasm	11	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	12	1.094638e-1	1.000000e+0	1.000000e+0	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	TPX2
Disease Ontology	DOID:3620	central nervous system neoplasm	12	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	13	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	TPX2
Disease Ontology	DOID:3094	neuroepithelial neoplasm	13	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	14	1.534735e-1	1.000000e+0	1.000000e+0	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	TPX2
Disease Ontology	DOID:3195	neural neoplasm	14	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	15	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	TPX2
Disease Ontology	DOID:3093	nervous system cancer	15	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	16	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	TPX2
Disease Ontology	DOID:936	brain disease	16	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	17	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	TPX2
Disease Ontology	DOID:155	glandular and epithelial neoplasm	17	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	19	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	TPX2
Disease Ontology	DOID:331	central nervous system disease	18	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	20	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	TPX2
Disease Ontology	DOID:863	nervous system disease	19	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	21	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	TPX2
Disease Ontology	DOID:305	carcinoma	20	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	22	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	TPX2
Disease Ontology	DOID:462	cancer by anatomical entity	21	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	23	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	TPX2
Disease Ontology	DOID:162	cancer	22	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	7	7.990207e-2	1.000000e+0	1.000000e+0	3.537451e+0	5.653789e-1	2	5100	1.000000e+0	3.921569e-4	unnamed	MYLK2,TPX2
Disease Ontology	DOID:7	disease of anatomical entity	23	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	24	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	TPX2
Disease Ontology	DOID:4	disease	24	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	18	1.910563e-1	1.000000e+0	1.000000e+0	2.287725e+0	8.742309e-1	2	7886	1.000000e+0	2.536140e-4	unnamed	MYLK2,TPX2
MSigDB Cancer Neighborhood	GNF2_MKI67	Neighborhood of MKI67	1	2.519239e-3	1.000000e+0	1.000000e+0	3.969452e+2	2.519239e-3	1	2.519239e-3	1.000000e+0	1	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_CKS1B	Neighborhood of CKS1B	2	2.584557e-3	1.000000e+0	5.518029e-1	3.869135e+2	2.584557e-3	1	2.584557e-3	1.000000e+0	3	4.208307e-3	1.000000e+0	5.989824e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_ESPL1	Neighborhood of ESPL1	3	2.616518e-3	1.000000e+0	3.724177e-1	3.821873e+2	2.616518e-3	1	2.616518e-3	1.000000e+0	2	3.987038e-3	1.000000e+0	8.512326e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_TTK	Neighborhood of TTK	4	3.029299e-3	1.000000e+0	3.233777e-1	3.301094e+2	3.029299e-3	1	3.029299e-3	1.000000e+0	4	4.318932e-3	1.000000e+0	4.610460e-1	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_CCNB2	Neighborhood of CCNB2	5	3.966642e-3	1.000000e+0	3.387512e-1	2.521024e+2	3.966642e-3	1	3.966642e-3	1.000000e+0	6	6.198618e-3	1.000000e+0	4.411350e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_CDC20	Neighborhood of CDC20	6	4.269394e-3	1.000000e+0	3.038385e-1	2.342253e+2	4.269394e-3	1	4.269394e-3	1.000000e+0	6	6.198618e-3	1.000000e+0	4.411350e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_CENPF	Neighborhood of CENPF	7	4.768483e-3	1.000000e+0	2.908775e-1	2.097103e+2	4.768483e-3	1	4.768483e-3	1.000000e+0	8	6.751129e-3	1.000000e+0	3.603415e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	MORF_BUB1	Neighborhood of BUB1	8	4.912564e-3	1.000000e+0	2.622081e-1	2.035597e+2	4.912564e-3	1	4.912564e-3	1.000000e+0	5	5.756499e-3	1.000000e+0	4.916050e-1	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_CCNA2	Neighborhood of CCNA2	9	5.608059e-3	1.000000e+0	2.660712e-1	1.783148e+2	5.608059e-3	1	5.608059e-3	1.000000e+0	12	7.524386e-3	1.000000e+0	2.677427e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_CDC2	Neighborhood of CDC2	10	5.654698e-3	1.000000e+0	2.414556e-1	1.768441e+2	5.654698e-3	1	5.654698e-3	1.000000e+0	8	6.751129e-3	1.000000e+0	3.603415e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	GNF2_PCNA	Neighborhood of PCNA	11	5.712645e-3	1.000000e+0	2.217545e-1	1.750503e+2	5.712645e-3	1	5.712645e-3	1.000000e+0	11	7.413939e-3	1.000000e+0	2.877956e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	TPX2
MSigDB Cancer Neighborhood	MORF_BUB1B	Neighborhood of BUB1B	12	5.830098e-3	1.000000e+0	2.074543e-1	1.715237e+2	5.830098e-3	1	5.830098e-3	1.000000e+0	10	7.303486e-3	1.000000e+0	3.118589e-1	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	TPX2
PANTHER Pathway	P00016	Cytoskeletal regulation by Rho GTPase	1	5.168257e-3	7.855751e-1	7.855751e-1	1.934888e+2	5.168257e-3	1	5.168257e-3	1.000000e+0	1	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	MYLK2
PANTHER Pathway	P00031	Inflammation mediated by chemokine and cytokine signaling pathway	2	1.674738e-2	1.000000e+0	1.000000e+0	5.971083e+1	1.674738e-2	1	1.674738e-2	1.000000e+0	2	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MYLK2
MSigDB Pathway	BIOCARTA_RANMS_PATHWAY	Role of Ran in mitotic spindle regulation	1	3.933498e-4	5.192217e-1	5.192217e-1	2.542267e+3	3.933498e-4	1	3.933498e-4	1.000000e+0	1	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	TPX2
MSigDB Pathway	PID_AURORA_A_PATHWAY	Aurora A signaling	2	1.916468e-3	1.000000e+0	1.000000e+0	5.217931e+2	1.916468e-3	1	1.916468e-3	1.000000e+0	2	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	TPX2
MSigDB Pathway	SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES	Genes related to regulation of the actin cytoskeleton	3	2.614491e-3	1.000000e+0	1.000000e+0	3.824836e+2	2.614491e-3	1	2.614491e-3	1.000000e+0	3	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	MYLK2
MSigDB Pathway	PID_PLK1_PATHWAY	PLK1 signaling events	4	3.339386e-3	1.000000e+0	1.000000e+0	2.994562e+2	3.339386e-3	1	3.339386e-3	1.000000e+0	4	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	TPX2
MSigDB Pathway	ST_FAS_SIGNALING_PATHWAY	Fas Signaling Pathway	5	4.472402e-3	1.000000e+0	1.000000e+0	2.235935e+2	4.472402e-3	1	4.472402e-3	1.000000e+0	6	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	TPX2
MSigDB Pathway	SIG_CHEMOTAXIS	Genes related to chemotaxis	6	4.787593e-3	1.000000e+0	1.000000e+0	2.088732e+2	4.787593e-3	1	4.787593e-3	1.000000e+0	5	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	MYLK2
MSigDB Pathway	ST_INTEGRIN_SIGNALING_PATHWAY	Integrin Signaling Pathway	7	8.840926e-3	1.000000e+0	1.000000e+0	1.131103e+2	8.840926e-3	1	8.840926e-3	1.000000e+0	7	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	MYLK2
MSigDB Pathway	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	Vascular smooth muscle contraction	8	1.349831e-2	1.000000e+0	1.000000e+0	7.408334e+1	1.349831e-2	1	1.349831e-2	1.000000e+0	8	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	MYLK2
MSigDB Pathway	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	Regulation of actin cytoskeleton	9	2.286325e-2	1.000000e+0	1.000000e+0	4.373832e+1	2.286325e-2	1	2.286325e-2	1.000000e+0	11	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	MYLK2
MSigDB Pathway	KEGG_FOCAL_ADHESION	Focal adhesion	10	2.318813e-2	1.000000e+0	1.000000e+0	4.312552e+1	2.318813e-2	1	2.318813e-2	1.000000e+0	10	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MYLK2
MSigDB Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	Calcium signaling pathway	11	2.453262e-2	1.000000e+0	1.000000e+0	4.076206e+1	2.453262e-2	1	2.453262e-2	1.000000e+0	9	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	MYLK2
MSigDB Perturbation	MIKKELSEN_IPS_LCP_WITH_H3K27ME3	Genes with low-CpG-density promoters (LCP) bearing the tri-methylation mark at H3K27 (H3K27me3) in MCV8.1 cells (induced pluripotent cells, iPS).	1	3.658390e-4	1.000000e+0	1.000000e+0	2.733443e+3	3.658390e-4	1	3.658390e-4	1.000000e+0	1	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MYLK2
MSigDB Perturbation	MIKKELSEN_ES_LCP_WITH_H3K27ME3	Genes with low-CpG-density promoters bearing H3 trimethylation mark at K27 (H3K27me3) in embryonic stem cells (ES).	2	5.553936e-4	1.000000e+0	9.341720e-1	1.800525e+3	5.553936e-4	1	5.553936e-4	1.000000e+0	2	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	MYLK2
MSigDB Perturbation	SMID_BREAST_CANCER_LUMINAL_A_DN	Genes down-regulated in the luminal A subtype of breast cancer.	3	6.451485e-4	1.000000e+0	7.234265e-1	1.550031e+3	6.451485e-4	1	6.451485e-4	1.000000e+0	4	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	TPX2
MSigDB Perturbation	SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	Cell cycle genes down-regulated in H1299 cells (lung cancer) after overexpression of either P53 or P73 [GeneID=7157;7161].	4	1.012957e-3	1.000000e+0	8.518968e-1	9.872083e+2	1.012957e-3	1	1.012957e-3	1.000000e+0	7	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	TPX2
MSigDB Perturbation	MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	Genes down-regulated in low grade (LMP and G1) serous ovarian carcinomas vs the higher grade invasive tumors (G2 and G3).	5	1.255298e-3	1.000000e+0	8.445645e-1	7.966236e+2	1.255298e-3	1	1.255298e-3	1.000000e+0	5	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	TPX2
MSigDB Perturbation	YUAN_ZNF143_PARTNERS	Proteins associated with ZNF143 [GeneID=7702] in HeLa cells, based on MudPIT analysis.	6	1.420975e-3	1.000000e+0	7.966933e-1	7.037421e+2	1.420975e-3	1	1.420975e-3	1.000000e+0	6	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	TPX2
MSigDB Perturbation	INAMURA_LUNG_CANCER_SCC_UP	Up-regulated genes characteristic to the squamous cell carcinoma (SCC) type of non-small cell lung cancer (NSCLC).	7	1.532854e-3	1.000000e+0	7.366458e-1	6.523779e+2	1.532854e-3	1	1.532854e-3	1.000000e+0	3	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	TPX2
MSigDB Perturbation	FARMER_BREAST_CANCER_CLUSTER_2	Cluster 2: selected proliferation and 8q amplicon genes clustered together across breast cancer samples.	8	2.677558e-3	1.000000e+0	1.000000e+0	3.734747e+2	2.677558e-3	1	2.677558e-3	1.000000e+0	9	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	TPX2
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_PR_UP	Top 50 up-regulated genes in cluster PR of multiple myeloma samples characterized by increased expression of proliferation and cell cycle genes.	9	2.778234e-3	1.000000e+0	1.000000e+0	3.599409e+2	2.778234e-3	1	2.778234e-3	1.000000e+0	10	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	TPX2
MSigDB Perturbation	DASU_IL6_SIGNALING_SCAR_UP	Genes up-regulated in hypertrophic scar fibroblasts in response to IL6 [GeneID=3569].	10	4.030841e-3	1.000000e+0	1.000000e+0	2.480872e+2	4.030841e-3	1	4.030841e-3	1.000000e+0	8	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	TPX2
MSigDB Perturbation	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	Genes downstream of both CDKN1A and TP53 [GeneID=1026;7157] in 2774qw1 cells (ovarian cancer).	11	4.159812e-3	1.000000e+0	1.000000e+0	2.403955e+2	4.159812e-3	1	4.159812e-3	1.000000e+0	14	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	TPX2
MSigDB Perturbation	KANG_DOXORUBICIN_RESISTANCE_UP	Genes up-regulated in gastric cancer cell lines: doxorubicin [PubChem=31703] resistant vs sensitive.	12	4.372260e-3	1.000000e+0	1.000000e+0	2.287147e+2	4.372260e-3	1	4.372260e-3	1.000000e+0	13	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	TPX2
MSigDB Perturbation	RHODES_CANCER_META_SIGNATURE	Genes commonly up-regulated in cancer relative to normal tissue, according to the meta-analysis of the OncoMine gene expression database.	13	4.789440e-3	1.000000e+0	1.000000e+0	2.087927e+2	4.789440e-3	1	4.789440e-3	1.000000e+0	18	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	TPX2
MSigDB Perturbation	KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	Genes down-regulated in C2AS12 cells (myoblast) by IGF1 [GeneID=3479] vs PDGFB [GeneID=5155].	14	5.192474e-3	1.000000e+0	1.000000e+0	1.925864e+2	5.192474e-3	1	5.192474e-3	1.000000e+0	11	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	TPX2
MSigDB Perturbation	OLSSON_E2F3_TARGETS_DN	Genes down-regulated in the 5637 cell line (bladder cancer) after knockdown of E2F3 [GeneID=1871] by RNAi.	15	5.298588e-3	1.000000e+0	1.000000e+0	1.887295e+2	5.298588e-3	1	5.298588e-3	1.000000e+0	19	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	TPX2
MSigDB Perturbation	TANG_SENESCENCE_TP53_TARGETS_DN	Genes down-regulated in WI-38 cells (senescent primary fibroblasts) after inactivation of TP53 [GeneID=7157] by GSE56 polypeptide.	16	5.622744e-3	1.000000e+0	1.000000e+0	1.778491e+2	5.622744e-3	1	5.622744e-3	1.000000e+0	16	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	TPX2
MSigDB Perturbation	SONG_TARGETS_OF_IE86_CMV_PROTEIN	Cellular genes up-regulated in forskin fibroblasts by expression of CMV EI86 protein off an adenovirus vector.	17	5.686757e-3	1.000000e+0	1.000000e+0	1.758472e+2	5.686757e-3	1	5.686757e-3	1.000000e+0	16	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	TPX2
MSigDB Perturbation	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	Genes commonly down-regulated in SK-N-BE cells (neuroblastoma) after RNAi knockdown of CCND1 and CDK4 [GeneID=595;1019].	18	5.768456e-3	1.000000e+0	1.000000e+0	1.733566e+2	5.768456e-3	1	5.768456e-3	1.000000e+0	15	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	TPX2
MSigDB Perturbation	CROONQUIST_NRAS_SIGNALING_DN	Genes down-regulated in ANBL-6 cell line (multiple myeloma, MM)  expressing a constantly active form of NRAS [GeneID=4893] off a plasmid vector compared to those grown in the presence of IL6 [GeneID=3569].	19	5.946711e-3	1.000000e+0	1.000000e+0	1.681602e+2	5.946711e-3	1	5.946711e-3	1.000000e+0	21	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	TPX2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_8HR_DN	Genes down-regulated in primary fibroblast cell culture point after infection with HCMV (AD169 strain) at 8 h time point that were not down-regulated at the previous time point, 6 h.	20	6.004735e-3	1.000000e+0	1.000000e+0	1.665352e+2	6.004735e-3	1	6.004735e-3	1.000000e+0	11	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	TPX2
MSigDB Perturbation	FURUKAWA_DUSP6_TARGETS_PCI35_DN	Genes down-regulated in PCI-35 cells (pancreatic cancer, lack endogenous DUSP6 [GeneID=1848]) upon expression of DUSP6 off an adenoviral vector.	21	6.134912e-3	1.000000e+0	9.827545e-1	1.630015e+2	6.134912e-3	1	6.134912e-3	1.000000e+0	20	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	TPX2
MSigDB Perturbation	PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	Genes up-regulated in OV-90 cells (ovarian cancer) exposed to ascites which inhibited invasion.	22	6.804697e-3	1.000000e+0	1.000000e+0	1.469573e+2	6.804697e-3	1	6.804697e-3	1.000000e+0	22	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	TPX2
MSigDB Perturbation	KONG_E2F3_TARGETS	Genes up-regulated in MEF cells (embryonic fibroblasts) at 16 hr after serum stimulation and knockdown of E2F3 [GeneID=1871] by RNAi.	23	7.082554e-3	1.000000e+0	1.000000e+0	1.411920e+2	7.082554e-3	1	7.082554e-3	1.000000e+0	28	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	TPX2
MSigDB Perturbation	SANA_RESPONSE_TO_IFNG_DN	Genes down-regulated in five primary endothelial cell types (lung, aortic, iliac, dermal, and colon) by IFNG [GeneID=3458].	24	7.548385e-3	1.000000e+0	1.000000e+0	1.324787e+2	7.548385e-3	1	7.548385e-3	1.000000e+0	23	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	TPX2
MSigDB Perturbation	CROONQUIST_IL6_DEPRIVATION_DN	Genes down-regulated in the ANBL-6 cell line (multiple myeloma, MM) after withdrawal of IL6 [GeneID=3569].	25	8.409895e-3	1.000000e+0	1.000000e+0	1.189075e+2	8.409895e-3	1	8.409895e-3	1.000000e+0	27	1.094519e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	99	5.000000e-1	1.010101e-2	unnamed	TPX2
MSigDB Perturbation	BHATTACHARYA_EMBRYONIC_STEM_CELL	The 'stemnes' signature: genes up-regulated and common to 6 human embryonic stem cell lines tested.	26	8.591115e-3	1.000000e+0	1.000000e+0	1.163993e+2	8.591115e-3	1	8.591115e-3	1.000000e+0	25	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	TPX2
MSigDB Perturbation	GAVIN_FOXP3_TARGETS_CLUSTER_P6	Cluster P6 of genes with similar expression profiles in peripheral T lymphocytes after FOXP3 [GeneID=50943] loss of function (LOF).	27	8.751543e-3	1.000000e+0	1.000000e+0	1.142656e+2	8.751543e-3	1	8.751543e-3	1.000000e+0	26	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	TPX2
MSigDB Perturbation	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	Up-regulated genes whose expression correlated with histologic grade of invasive breast cancer tumors: comparison of grade 1 vs grade 3.	28	9.817439e-3	1.000000e+0	1.000000e+0	1.018596e+2	9.817439e-3	1	9.817439e-3	1.000000e+0	37	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	TPX2
MSigDB Perturbation	BASSO_B_LYMPHOCYTE_NETWORK	Genes which comprise the top 1% of highly interconnected genes (major hubs) that account for most of gene interactions in the reconstructed regulatory networks from expression profiles in B lymphocytes.	29	1.057384e-2	1.000000e+0	1.000000e+0	9.457301e+1	1.057384e-2	1	1.057384e-2	1.000000e+0	34	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	TPX2
MSigDB Perturbation	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	The 'Cervical Cancer Proliferation Cluster' (CCPC): genes whose expression in cervical carcinoma positively correlates with that of the HPV E6 and E7 oncogenes; they are also differentially expressed according to disease outcome.	30	1.069990e-2	1.000000e+0	1.000000e+0	9.345884e+1	1.069990e-2	1	1.069990e-2	1.000000e+0	35	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	TPX2
MSigDB Perturbation	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	Top 100 probe sets contrubuting to the positive side of the 2nd principal component; associated with adipocytic differentiation.	31	1.142667e-2	1.000000e+0	1.000000e+0	8.751454e+1	1.142667e-2	1	1.142667e-2	1.000000e+0	24	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	TPX2
MSigDB Perturbation	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	Genes up-regulated in CD4+ [GeneID=920] T lymphocytes after stimulation with prostaglandin E2 [PubChem=5280360].	32	1.145625e-2	1.000000e+0	1.000000e+0	8.728856e+1	1.145625e-2	1	1.145625e-2	1.000000e+0	33	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	TPX2
MSigDB Perturbation	SMIRNOV_RESPONSE_TO_IR_6HR_DN	Genes down-regulated in B lymphocytes at 6 h after exprosure to 10 Gy dose of ionizing radiation.	33	1.159726e-2	1.000000e+0	1.000000e+0	8.622725e+1	1.159726e-2	1	1.159726e-2	1.000000e+0	29	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	TPX2
MSigDB Perturbation	WHITEFORD_PEDIATRIC_CANCER_MARKERS	Differentially expressed genes in a panel of xenografts representing 8 common pediatric tumors compared to the normal tissues.	34	1.184154e-2	1.000000e+0	1.000000e+0	8.444848e+1	1.184154e-2	1	1.184154e-2	1.000000e+0	31	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	TPX2
MSigDB Perturbation	CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	Genes down-regulated in ANBL-6 cell line (multiple myeloma, MM) expressing an activated form of NRAS [GeneID=4893] off a plasmid vector compared to those co-cultured with bone marrow stromal cells.	35	1.231498e-2	1.000000e+0	1.000000e+0	8.120195e+1	1.231498e-2	1	1.231498e-2	1.000000e+0	29	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	TPX2
MSigDB Perturbation	CHANG_CYCLING_GENES	Fibroblast serum response genes showing periodic expression during the cell cycle; excluded from the core serum response signature.	36	1.263702e-2	1.000000e+0	1.000000e+0	7.913256e+1	1.263702e-2	1	1.263702e-2	1.000000e+0	35	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	TPX2
MSigDB Perturbation	SERVITJA_LIVER_HNF1A_TARGETS_UP	Genes up-regulated in liver tissue upon knockout of HNF1A [GeneID=6927].	37	1.396256e-2	1.000000e+0	1.000000e+0	7.162009e+1	1.396256e-2	1	1.396256e-2	1.000000e+0	32	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	TPX2
MSigDB Perturbation	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	Genes up-regulated in genomically unstable Ewing's sarcoma tumors compared to the stable ones.	38	1.520323e-2	1.000000e+0	1.000000e+0	6.577549e+1	1.520323e-2	1	1.520323e-2	1.000000e+0	38	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	TPX2
MSigDB Perturbation	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	Genes down-regulated in Wilm's tumor samples compared to fetal  kidney.	39	1.583386e-2	1.000000e+0	1.000000e+0	6.315578e+1	1.583386e-2	1	1.583386e-2	1.000000e+0	38	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	TPX2
MSigDB Perturbation	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	Genes up-regulated in quiescent CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors compared to the dividing cells from CML (chronic myeloid leukemia) patients.	40	1.595697e-2	1.000000e+0	1.000000e+0	6.266855e+1	1.595697e-2	1	1.595697e-2	1.000000e+0	40	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	TPX2
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	Marker genes down-regulated in the 'unannotated' subclass of hepatocellular carcinoma (HCC) samples.	41	1.636872e-2	1.000000e+0	1.000000e+0	6.109215e+1	1.636872e-2	1	1.636872e-2	1.000000e+0	45	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	TPX2
MSigDB Perturbation	BIDUS_METASTASIS_UP	Genes up-regulated in endometroid endometrial tumors from patients with lymph node metastases compared to those without the metastases.	42	1.803475e-2	1.000000e+0	1.000000e+0	5.544850e+1	1.803475e-2	1	1.803475e-2	1.000000e+0	47	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	TPX2
MSigDB Perturbation	MANALO_HYPOXIA_DN	Genes down-regulated in response to both hypoxia and overexpression of an active form of HIF1A [GeneID=3091].	43	1.907423e-2	1.000000e+0	1.000000e+0	5.242677e+1	1.907423e-2	1	1.907423e-2	1.000000e+0	56	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	TPX2
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	Top 200 marker genes up-regulated in the 'proliferation' subclass of hepatocellular carcinoma (HCC); characterized by increased proliferation, high levels of serum AFP [GeneID=174], and chromosomal instability.	44	1.975809e-2	1.000000e+0	1.000000e+0	5.061219e+1	1.975809e-2	1	1.975809e-2	1.000000e+0	43	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	TPX2
MSigDB Perturbation	ZHANG_TLX_TARGETS_36HR_DN	Genes down-regulated in neural stem cells (NSC) at 36 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	45	2.068375e-2	1.000000e+0	1.000000e+0	4.834713e+1	2.068375e-2	1	2.068375e-2	1.000000e+0	41	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	TPX2
MSigDB Perturbation	ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	Genes down-regulated in acute myeloid leukemia (AML) with respect to cellular localization of NPM1 [GeneID=4869]: cytoplasmic vs. nucleolar.	46	2.108944e-2	1.000000e+0	1.000000e+0	4.741710e+1	2.108944e-2	1	2.108944e-2	1.000000e+0	41	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	TPX2
MSigDB Perturbation	WHITFIELD_CELL_CYCLE_G2_M	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G2/M phase of cell cycle.	47	2.131411e-2	1.000000e+0	1.000000e+0	4.691729e+1	2.131411e-2	1	2.131411e-2	1.000000e+0	49	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	TPX2
MSigDB Perturbation	SASAKI_ADULT_T_CELL_LEUKEMIA	Genes up-regulated in adult T-cell leukemia (ATL) cells compared to T lymphocytes from healthy controls.	48	2.133045e-2	1.000000e+0	1.000000e+0	4.688133e+1	2.133045e-2	1	2.133045e-2	1.000000e+0	44	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	TPX2
MSigDB Perturbation	KOBAYASHI_EGFR_SIGNALING_24HR_DN	Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.	49	2.179460e-2	1.000000e+0	1.000000e+0	4.588292e+1	2.179460e-2	1	2.179460e-2	1.000000e+0	53	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	TPX2
MSigDB Perturbation	PEDRIOLI_MIR31_TARGETS_UP	Genes up-regulated in primary LEC cells (lymphatic endothelum) upon overexpression of MIR31 [GeneID=407035].	50	2.222875e-2	1.000000e+0	1.000000e+0	4.498679e+1	2.222875e-2	1	2.222875e-2	1.000000e+0	46	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MYLK2
MSigDB Perturbation	MUELLER_PLURINET	Genes constituting the PluriNet protein-protein network shared by the pluripotent cells (embryonic stem cells, embryonical carcinomas and induced pluripotent cells).	51	2.247319e-2	1.000000e+0	1.000000e+0	4.449746e+1	2.247319e-2	1	2.247319e-2	1.000000e+0	59	3.341799e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	304	5.000000e-1	3.289474e-3	unnamed	TPX2
MSigDB Perturbation	CHANDRAN_METASTASIS_UP	Genes up-regulated in metastatic tumors from the whole panel of patients with prostate cancer.	52	2.270884e-2	1.000000e+0	1.000000e+0	4.403572e+1	2.270884e-2	1	2.270884e-2	1.000000e+0	48	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	TPX2
MSigDB Perturbation	WEST_ADRENOCORTICAL_TUMOR_UP	Up-regulated genes in pediatric adrenocortical tumors (ACT) compared to the normal tissue.	53	2.394855e-2	1.000000e+0	1.000000e+0	4.175618e+1	2.394855e-2	1	2.394855e-2	1.000000e+0	58	3.221869e-2	1.000000e+0	1.000000e+0	3.078669e+1	3.248157e-2	1	293	5.000000e-1	3.412969e-3	unnamed	TPX2
MSigDB Perturbation	LEI_MYB_TARGETS	Myb-regulated genes in MCF7 (breast cancer) and lung epithelial cell lines overexpressing MYBL2, MYBL1 or MYB [GeneID=4605;4603;4602].	54	2.437585e-2	1.000000e+0	1.000000e+0	4.102422e+1	2.437585e-2	1	2.437585e-2	1.000000e+0	61	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	TPX2
MSigDB Perturbation	BASAKI_YBX1_TARGETS_UP	Genes up-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.	55	2.464082e-2	1.000000e+0	1.000000e+0	4.058307e+1	2.464082e-2	1	2.464082e-2	1.000000e+0	57	3.134601e-2	1.000000e+0	1.000000e+0	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	TPX2
MSigDB Perturbation	MITSIADES_RESPONSE_TO_APLIDIN_DN	Genes down-regulated in the MM1S cells (multiple myeloma) after treatment with aplidin [PubChem=44152164], a marine-derived compound with potential anti-cancer properties.	56	2.562386e-2	1.000000e+0	1.000000e+0	3.902613e+1	2.562386e-2	1	2.562386e-2	1.000000e+0	51	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	TPX2
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	Genes up-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.	57	2.658375e-2	1.000000e+0	1.000000e+0	3.761697e+1	2.658375e-2	1	2.658375e-2	1.000000e+0	62	3.494330e-2	1.000000e+0	1.000000e+0	2.836635e+1	3.525303e-2	1	318	5.000000e-1	3.144654e-3	unnamed	TPX2
MSigDB Perturbation	HORIUCHI_WTAP_TARGETS_DN	Genes down-regulated in primary endothelial cells (HUVEC) after knockdown of WTAP [GeneID=9589] by RNAi.	58	2.665398e-2	1.000000e+0	1.000000e+0	3.751785e+1	2.665398e-2	1	2.665398e-2	1.000000e+0	63	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	TPX2
MSigDB Perturbation	POOLA_INVASIVE_BREAST_CANCER_UP	Genes up-regulated in atypical ductal hyperplastic tissues from patients with (ADHC) breast cancer vs those without the cancer (ADH).	59	2.677237e-2	1.000000e+0	1.000000e+0	3.735195e+1	2.677237e-2	1	2.677237e-2	1.000000e+0	54	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	TPX2
MSigDB Perturbation	BORCZUK_MALIGNANT_MESOTHELIOMA_UP	Genes up-regulated in biphasic (mixed) vs epithelial subtypes of malignant peritoneal mesothelioma.	60	2.747149e-2	1.000000e+0	1.000000e+0	3.640137e+1	2.747149e-2	1	2.747149e-2	1.000000e+0	60	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	TPX2
MSigDB Perturbation	ROZANOV_MMP14_TARGETS_UP	Genes up-regulated in HT1080 cells (fibrosarcoma) over-expressing MMP14 [GeneID=4323] compared to those with knockdown of the gene by RNAi.	61	2.785368e-2	1.000000e+0	1.000000e+0	3.590190e+1	2.785368e-2	1	2.785368e-2	1.000000e+0	55	3.025460e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	275	5.000000e-1	3.636364e-3	unnamed	MYLK2
MSigDB Perturbation	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	The glioblastoma multiforme (GBM) plasticity signature: genes up-regulated in neural stem cells (NSC) with double knockout of TP53 and PTEN [GeneID=7157;5728] vs those with knockout of TP53 alone.	62	3.204692e-2	1.000000e+0	1.000000e+0	3.120425e+1	3.204692e-2	1	3.204692e-2	1.000000e+0	52	2.839779e-2	1.000000e+0	1.000000e+0	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	TPX2
MSigDB Perturbation	VECCHI_GASTRIC_CANCER_EARLY_UP	Up-regulated genes distinguishing between early gastric cancer (EGC) and normal tissue samples.	63	3.247479e-2	1.000000e+0	1.000000e+0	3.079312e+1	3.247479e-2	1	3.247479e-2	1.000000e+0	67	4.352782e-2	1.000000e+0	1.000000e+0	2.272166e+1	4.401086e-2	1	397	5.000000e-1	2.518892e-3	unnamed	TPX2
MSigDB Perturbation	BLUM_RESPONSE_TO_SALIRASIB_DN	Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].	64	3.335018e-2	1.000000e+0	1.000000e+0	2.998484e+1	3.335018e-2	1	3.335018e-2	1.000000e+0	65	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	TPX2
MSigDB Perturbation	CHICAS_RB1_TARGETS_GROWING	Genes up-regulated in growing IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	65	3.635781e-2	1.000000e+0	1.000000e+0	2.750440e+1	3.635781e-2	1	3.635781e-2	1.000000e+0	50	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	TPX2
MSigDB Perturbation	PUJANA_BRCA2_PCC_NETWORK	Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.	66	3.791785e-2	1.000000e+0	1.000000e+0	2.637280e+1	3.791785e-2	1	3.791785e-2	1.000000e+0	69	4.569503e-2	1.000000e+0	1.000000e+0	2.163189e+1	4.622804e-2	1	417	5.000000e-1	2.398082e-3	unnamed	TPX2
MSigDB Perturbation	COLINA_TARGETS_OF_4EBP1_AND_4EBP2	Genes up-regulated in MEF cells (embryonic fibroblast) with double knockout of the translation repressors 4EBP1 [GeneID=1978] and 4EBP2 [GeneID=1979].	67	3.828136e-2	1.000000e+0	1.000000e+0	2.612237e+1	3.828136e-2	1	3.828136e-2	1.000000e+0	66	3.907735e-2	1.000000e+0	1.000000e+0	2.533848e+1	3.946566e-2	1	356	5.000000e-1	2.808989e-3	unnamed	TPX2
MSigDB Perturbation	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	Cluster 6 of method A: up-regulation of these genes in patients with non-small cell lung cancer (NSCLC) predicts poor survival outcome.	68	3.969311e-2	1.000000e+0	1.000000e+0	2.519329e+1	3.969311e-2	1	3.969311e-2	1.000000e+0	71	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	TPX2
MSigDB Perturbation	CAIRO_HEPATOBLASTOMA_CLASSES_UP	Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).	69	3.989950e-2	1.000000e+0	1.000000e+0	2.506297e+1	3.989950e-2	1	3.989950e-2	1.000000e+0	75	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	TPX2
MSigDB Perturbation	FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	Genes which best discriminated between two groups of breast cancer according to the status of ESR1 and AR [GeneID=2099;367]: basal (ESR1- AR-) and luminal (ESR1+ AR+).	70	4.119949e-2	1.000000e+0	1.000000e+0	2.427215e+1	4.119949e-2	1	4.119949e-2	1.000000e+0	64	3.537888e-2	1.000000e+0	1.000000e+0	2.801398e+1	3.569647e-2	1	322	5.000000e-1	3.105590e-3	unnamed	TPX2
MSigDB Perturbation	MARSON_BOUND_BY_E2F4_UNSTIMULATED	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	71	4.167922e-2	1.000000e+0	1.000000e+0	2.399277e+1	4.167922e-2	1	4.167922e-2	1.000000e+0	78	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	TPX2
MSigDB Perturbation	CUI_TCF21_TARGETS_2_UP	All significantly up-regulated genes in kidney glomeruli isolated from TCF21 [Gene ID=6943] knockout mice.	72	4.545878e-2	1.000000e+0	1.000000e+0	2.199795e+1	4.545878e-2	1	4.545878e-2	1.000000e+0	68	4.547842e-2	1.000000e+0	1.000000e+0	2.173614e+1	4.600632e-2	1	415	5.000000e-1	2.409639e-3	unnamed	TPX2
MSigDB Perturbation	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	Genes up-regulated during later stage of differentiation of Oli-Neu cells (oligodendroglial precursor) in response to PD174265 [PubChemID=4709].	73	4.971953e-2	1.000000e+0	1.000000e+0	2.011282e+1	4.971953e-2	1	4.971953e-2	1.000000e+0	74	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	TPX2
MSigDB Perturbation	ENK_UV_RESPONSE_KERATINOCYTE_DN	Genes down-regulated in NHEK cells (normal epidermal keratinocytes) after UVB irradiation.	74	5.492266e-2	1.000000e+0	1.000000e+0	1.820742e+1	5.492266e-2	1	5.492266e-2	1.000000e+0	73	5.477048e-2	1.000000e+0	1.000000e+0	1.800499e+1	5.554016e-2	1	501	5.000000e-1	1.996008e-3	unnamed	TPX2
MSigDB Perturbation	BENPORATH_CYCLING_GENES	Genes showing cell-cycle stage-specific expression [PMID=12058064].	75	5.607900e-2	1.000000e+0	1.000000e+0	1.783199e+1	5.607900e-2	1	5.607900e-2	1.000000e+0	77	7.022751e-2	1.000000e+0	1.000000e+0	1.398527e+1	7.150380e-2	1	645	5.000000e-1	1.550388e-3	unnamed	TPX2
MSigDB Perturbation	PUJANA_CHEK2_PCC_NETWORK	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC &gt;= 0.4) with that of CHEK2 [GeneID=11200].	76	5.889590e-2	1.000000e+0	1.000000e+0	1.697911e+1	5.889590e-2	1	5.889590e-2	1.000000e+0	81	8.608710e-2	1.000000e+0	1.000000e+0	1.136083e+1	8.802173e-2	1	794	5.000000e-1	1.259446e-3	unnamed	TPX2
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	The 'group 1 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 and ERBB2 [GeneID=2099;2064].	77	5.895188e-2	1.000000e+0	1.000000e+0	1.696299e+1	5.895188e-2	1	5.895188e-2	1.000000e+0	72	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	TPX2
MSigDB Perturbation	PATIL_LIVER_CANCER	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	78	5.982431e-2	1.000000e+0	1.000000e+0	1.671561e+1	5.982431e-2	1	5.982431e-2	1.000000e+0	80	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	TPX2
MSigDB Perturbation	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	Genes up-regulated in cultured stromal stem cells from adipose tissue, compared to the freshly isolated cells.	79	6.459289e-2	1.000000e+0	1.000000e+0	1.548158e+1	6.459289e-2	1	6.459289e-2	1.000000e+0	70	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	TPX2
MSigDB Perturbation	SMID_BREAST_CANCER_BASAL_UP	Genes up-regulated in basal subtype of breast cancer samles.	80	7.093597e-2	1.000000e+0	1.000000e+0	1.409722e+1	7.093597e-2	1	7.093597e-2	1.000000e+0	76	6.840935e-2	1.000000e+0	1.000000e+0	1.436385e+1	6.961920e-2	1	628	5.000000e-1	1.592357e-3	unnamed	TPX2
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	Genes up-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	81	7.606396e-2	1.000000e+0	1.000000e+0	1.314683e+1	7.606396e-2	1	7.606396e-2	1.000000e+0	79	7.694989e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	TPX2
MSigDB Perturbation	NUYTTEN_EZH2_TARGETS_DN	Genes down-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	82	8.521044e-2	1.000000e+0	1.000000e+0	1.173565e+1	8.521044e-2	1	8.521044e-2	1.000000e+0	83	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	TPX2
MSigDB Perturbation	BENPORATH_NANOG_TARGETS	Set 'Nanog targets': genes upregulated and identified by ChIP on chip as Nanog [GeneID=79923] transcription factor targets in human embryonic stem cells.	83	1.005508e-1	1.000000e+0	1.000000e+0	9.945225e+0	1.005508e-1	1	1.005508e-1	1.000000e+0	82	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	TPX2
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	84	1.219335e-1	1.000000e+0	1.000000e+0	8.201193e+0	1.219335e-1	1	1.219335e-1	1.000000e+0	84	1.314014e-1	1.000000e+0	1.000000e+0	7.351671e+0	1.360235e-1	1	1227	5.000000e-1	8.149959e-4	unnamed	TPX2
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_DN	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	85	1.258050e-1	1.000000e+0	1.000000e+0	7.948812e+0	1.258050e-1	1	1.258050e-1	1.000000e+0	85	1.382073e-1	1.000000e+0	1.000000e+0	6.976411e+0	1.433402e-1	1	1293	5.000000e-1	7.733952e-4	unnamed	TPX2
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	86	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	86	1.731460e-1	1.000000e+0	1.000000e+0	5.513753e+0	1.813647e-1	1	1636	5.000000e-1	6.112469e-4	unnamed	TPX2
MSigDB Predicted Promoter Motifs	V$TFIII_Q6	Motif RGAGGKAGG matches GTF2A1: general transcription factor IIA, 1, 19/37kDa&lt;br&gt; GTF2A2: general transcription factor IIA, 2, 12kDa	1	2.259660e-2	1.000000e+0	1.000000e+0	4.425445e+1	2.259660e-2	1	2.259660e-2	1.000000e+0	1	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	V$T3R_Q6	Motif MNTGWCCTN (no known TF)	2	2.901832e-2	1.000000e+0	1.000000e+0	3.446099e+1	2.901832e-2	1	2.901832e-2	1.000000e+0	4	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	V$E12_Q6	Motif RRCAGGTGNCV matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	3	3.028492e-2	1.000000e+0	1.000000e+0	3.301973e+1	3.028492e-2	1	3.028492e-2	1.000000e+0	6	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	V$MYOD_Q6	Motif NNCACCTGNY matches MYOD1: myogenic differentiation 1	4	3.047223e-2	1.000000e+0	1.000000e+0	3.281676e+1	3.047223e-2	1	3.047223e-2	1.000000e+0	3	2.621103e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	238	5.000000e-1	4.201681e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	V$NF1_Q6	Motif NNTTGGCNNNNNNCCNNN matches NF1: neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	5	3.110640e-2	1.000000e+0	1.000000e+0	3.214773e+1	3.110640e-2	1	3.110640e-2	1.000000e+0	5	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	V$NF1_Q6_01	Motif NTGGNNNNNNGCCAANN matches NF1: neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	6	3.264873e-2	1.000000e+0	1.000000e+0	3.062906e+1	3.264873e-2	1	3.264873e-2	1.000000e+0	7	2.817922e-2	1.000000e+0	1.000000e+0	3.523633e+1	2.837980e-2	1	256	5.000000e-1	3.906250e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	V$MEIS1_01	Motif NNNTGACAGNNN matches MEIS1: Meis1, myeloid ecotropic viral integration site 1 homolog (mouse)	7	3.506399e-2	1.000000e+0	1.000000e+0	2.851928e+1	3.506399e-2	1	3.506399e-2	1.000000e+0	2	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	SCGGAAGY_V$ELK1_02	Motif SCGGAAGY matches ELK1: ELK1, member of ETS oncogene family	8	7.801699e-2	1.000000e+0	1.000000e+0	1.281772e+1	7.801699e-2	1	7.801699e-2	1.000000e+0	11	1.233236e-1	1.000000e+0	1.000000e+0	7.850740e+0	1.273765e-1	1	1149	5.000000e-1	8.703220e-4	unnamed	TPX2
MSigDB Predicted Promoter Motifs	CTGCAGY_UNKNOWN	Motif CTGCAGY (no known TF)	9	1.078530e-1	1.000000e+0	1.000000e+0	9.271883e+0	1.078530e-1	1	1.078530e-1	1.000000e+0	8	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	GATTGGY_V$NFY_Q6_01	Motif GATTGGY (no known TF)	10	1.117321e-1	1.000000e+0	1.000000e+0	8.949976e+0	1.117321e-1	1	1.117321e-1	1.000000e+0	10	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	TPX2
MSigDB Predicted Promoter Motifs	TGACAGNY_V$MEIS1_01	Motif TGACAGNY matches MEIS1: Meis1, myeloid ecotropic viral integration site 1 homolog (mouse)	11	1.133519e-1	1.000000e+0	1.000000e+0	8.822084e+0	1.133519e-1	1	1.133519e-1	1.000000e+0	9	8.566313e-2	1.000000e+0	1.000000e+0	1.141835e+1	8.757829e-2	1	790	5.000000e-1	1.265823e-3	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	GGGAGGRR_V$MAZ_Q6	Motif GGGAGGRR matches MAZ: MYC-associated zinc finger protein (purine-binding transcription factor)	12	2.285624e-1	1.000000e+0	1.000000e+0	4.375173e+0	2.285624e-1	1	2.285624e-1	1.000000e+0	12	2.271738e-1	1.000000e+0	1.000000e+0	4.135947e+0	2.417826e-1	1	2181	5.000000e-1	4.585053e-4	unnamed	MYLK2
MSigDB Predicted Promoter Motifs	CAGGTG_V$E12_Q6	Motif CAGGTG matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	13	2.657598e-1	1.000000e+0	1.000000e+0	3.762796e+0	2.657598e-1	1	2.657598e-1	1.000000e+0	13	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	MYLK2
MSigDB miRNA Motifs	CCACACA,MIR-147	Targets of MicroRNA CCACACA,MIR-147	1	8.128582e-3	1.000000e+0	1.000000e+0	1.230227e+2	8.128582e-3	1	8.128582e-3	1.000000e+0	1	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	MYLK2
MSigDB miRNA Motifs	GTGCCTT,MIR-506	Targets of MicroRNA GTGCCTT,MIR-506	2	8.853209e-2	1.000000e+0	1.000000e+0	1.129534e+1	8.853209e-2	1	8.853209e-2	1.000000e+0	2	7.588448e-2	1.000000e+0	1.000000e+0	1.292335e+1	7.737930e-2	1	698	5.000000e-1	1.432665e-3	unnamed	MYLK2
InterPro	IPR009675	TPX2	1	3.019869e-5	2.845321e-1	2.845321e-1	3.311402e+4	3.019869e-5	1	3.019869e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TPX2
InterPro	IPR015128	Aurora-A binding	1	3.019869e-5	2.845321e-1	2.845321e-1	3.311402e+4	3.019869e-5	1	3.019869e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TPX2
InterPro	IPR027329	TPX2, C-terminal domain	1	3.019869e-5	2.845321e-1	2.845321e-1	3.311402e+4	3.019869e-5	1	3.019869e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TPX2
InterPro	IPR027330	TPX2 central domain	1	3.019869e-5	2.845321e-1	2.845321e-1	3.311402e+4	3.019869e-5	1	3.019869e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TPX2
InterPro	IPR020636	Calcium/calmodulin-dependent/calcium-dependent protein kinase	5	2.873285e-3	1.000000e+0	1.000000e+0	3.480337e+2	2.873285e-3	1	2.873285e-3	1.000000e+0	5	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	MYLK2
InterPro	IPR002290	Serine/threonine- / dual specificity protein kinase, catalytic  domain	6	2.828392e-2	1.000000e+0	1.000000e+0	3.535578e+1	2.828392e-2	1	2.828392e-2	1.000000e+0	6	2.916257e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	MYLK2
InterPro	IPR008271	Serine/threonine-protein kinase, active site	7	3.300870e-2	1.000000e+0	1.000000e+0	3.029504e+1	3.300870e-2	1	3.300870e-2	1.000000e+0	7	3.407184e-2	1.000000e+0	1.000000e+0	2.909839e+1	3.436617e-2	1	310	5.000000e-1	3.225806e-3	unnamed	MYLK2
InterPro	IPR017441	Protein kinase, ATP binding site	8	4.306472e-2	1.000000e+0	1.000000e+0	2.322086e+1	4.306472e-2	1	4.306472e-2	1.000000e+0	8	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	MYLK2
InterPro	IPR000719	Protein kinase domain	9	5.435495e-2	1.000000e+0	1.000000e+0	1.839759e+1	5.435495e-2	1	5.435495e-2	1.000000e+0	9	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	MYLK2
InterPro	IPR011009	Protein kinase-like domain	10	5.858948e-2	1.000000e+0	1.000000e+0	1.706791e+1	5.858948e-2	1	5.858948e-2	1.000000e+0	10	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	MYLK2
TreeFam	TF328997	TPX2	1	3.019869e-5	2.453946e-1	2.453946e-1	3.311402e+4	3.019869e-5	1	3.019869e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TPX2
Ensembl Genes	12147	TPX2	1	3.019869e-5	5.448146e-1	5.448146e-1	3.311402e+4	3.019869e-5	1	3.019869e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TPX2
Ensembl Genes	12148	MYLK2	2	3.646776e-5	6.579149e-1	3.289574e-1	2.742148e+4	3.646776e-5	1	3.646776e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MYLK2
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h.	1	1.018445e-2	1.000000e+0	1.000000e+0	9.818892e+1	1.018445e-2	1	1.018445e-2	1.000000e+0	14	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 24 h.	2	1.065271e-2	1.000000e+0	1.000000e+0	9.387285e+1	1.065271e-2	1	1.065271e-2	1.000000e+0	8	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from young donors versus those treated with TSST at 40 h.	3	1.210140e-2	1.000000e+0	1.000000e+0	8.263508e+1	1.210140e-2	1	1.210140e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7.	4	1.358914e-2	1.000000e+0	1.000000e+0	7.358818e+1	1.358914e-2	1	1.358914e-2	1.000000e+0	45	2.336458e-2	1.000000e+0	9.916966e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 72 h.	5	1.402503e-2	1.000000e+0	1.000000e+0	7.130110e+1	1.402503e-2	1	1.402503e-2	1.000000e+0	37	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] memory T cells from old donors versus those treated with TSST at 40 h.	6	1.414665e-2	1.000000e+0	1.000000e+0	7.068811e+1	1.414665e-2	1	1.414665e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP	Genes up-regulated in comparison of plasma cells versus memory B cells.	7	1.426843e-2	1.000000e+0	1.000000e+0	7.008478e+1	1.426843e-2	1	1.426843e-2	1.000000e+0	45	2.336458e-2	1.000000e+0	9.916966e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP	Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7 versus CD25- T cells treated with IL4 [GeneID=3565] at day 7.	8	1.440429e-2	1.000000e+0	1.000000e+0	6.942377e+1	1.440429e-2	1	1.440429e-2	1.000000e+0	43	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	9	1.440843e-2	1.000000e+0	1.000000e+0	6.940379e+1	1.440843e-2	1	1.440843e-2	1.000000e+0	2	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	MYLK2
MSigDB Immunologic Signatures	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus Th1 cells.	10	1.482910e-2	1.000000e+0	1.000000e+0	6.743496e+1	1.482910e-2	1	1.482910e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN	Genes down-regulated in comparison of naive B cells versus plasma cells.	11	1.485062e-2	1.000000e+0	1.000000e+0	6.733726e+1	1.485062e-2	1	1.485062e-2	1.000000e+0	41	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 12 h.	12	1.504942e-2	1.000000e+0	1.000000e+0	6.644772e+1	1.504942e-2	1	1.504942e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MYLK2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	13	1.533917e-2	1.000000e+0	1.000000e+0	6.519258e+1	1.533917e-2	1	1.533917e-2	1.000000e+0	21	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_LPS_1H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 1 h versus those stimulated with LPS (TLR4 agonist) at 1 h.	14	1.546965e-2	1.000000e+0	1.000000e+0	6.464272e+1	1.546965e-2	1	1.546965e-2	1.000000e+0	39	2.248791e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	204	5.000000e-1	4.901961e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10.	15	1.548414e-2	1.000000e+0	1.000000e+0	6.458221e+1	1.548414e-2	1	1.548414e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP	Genes up-regulated in comparison of CD25- T cells treated with IL4 [GeneID=3565] at day 7 versus untreated CD25- T cells at day 7.	16	1.549828e-2	1.000000e+0	1.000000e+0	6.452330e+1	1.549828e-2	1	1.549828e-2	1.000000e+0	42	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	17	1.559108e-2	1.000000e+0	1.000000e+0	6.413926e+1	1.559108e-2	1	1.559108e-2	1.000000e+0	12	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of wild type CD8 effector T cells at day 6 versus those  from mice defficient for TRAF6 [GeneID=7189] at day 10.	18	1.571267e-2	1.000000e+0	1.000000e+0	6.364290e+1	1.571267e-2	1	1.571267e-2	1.000000e+0	24	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of wild type CD8 effector T cells at day 6 versus those at day 10.	19	1.635850e-2	1.000000e+0	1.000000e+0	6.113031e+1	1.635850e-2	1	1.635850e-2	1.000000e+0	15	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN	Genes down-regulated in comparison of IgM-memory B cells versus plasma cells.	20	1.662974e-2	1.000000e+0	1.000000e+0	6.013323e+1	1.662974e-2	1	1.662974e-2	1.000000e+0	43	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those from day 7 post-vaccination.	21	1.713188e-2	1.000000e+0	1.000000e+0	5.837072e+1	1.713188e-2	1	1.713188e-2	1.000000e+0	12	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE3982_NKCELL_VS_TH1_DN	Genes down-regulated in comparison of NK cells versus Th1 cells.	22	1.767959e-2	1.000000e+0	1.000000e+0	5.656238e+1	1.767959e-2	1	1.767959e-2	1.000000e+0	20	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN	Genes down-regulated in comparison of thymic progenitors versus DN2 thymocytes.	23	1.775644e-2	1.000000e+0	1.000000e+0	5.631760e+1	1.775644e-2	1	1.775644e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE3982_DC_VS_BCELL_DN	Genes down-regulated in comparison of dendritic cells (DC) versus B cells.	24	1.779031e-2	1.000000e+0	1.000000e+0	5.621038e+1	1.779031e-2	1	1.779031e-2	1.000000e+0	6	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	25	1.795528e-2	1.000000e+0	1.000000e+0	5.569392e+1	1.795528e-2	1	1.795528e-2	1.000000e+0	19	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h.	26	1.803246e-2	1.000000e+0	1.000000e+0	5.545556e+1	1.803246e-2	1	1.803246e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 8 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 8 h.	27	1.818029e-2	1.000000e+0	1.000000e+0	5.500462e+1	1.818029e-2	1	1.818029e-2	1.000000e+0	15	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	MYLK2
MSigDB Immunologic Signatures	GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP	Genes up-regulated in comparison of CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 10 versus CD25- T cells treated with IL4 [GeneID=3565] at 10 h.	28	1.820703e-2	1.000000e+0	1.000000e+0	5.492384e+1	1.820703e-2	1	1.820703e-2	1.000000e+0	24	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN	Genes down-regulated in comparison of Ig isotype switched memory B cells versus plasma cells.	29	1.826753e-2	1.000000e+0	1.000000e+0	5.474193e+1	1.826753e-2	1	1.826753e-2	1.000000e+0	40	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE22045_TREG_VS_TCONV_UP	Genes up-regulated in comparison of regulatory T cell (Treg) versus conventional T cells.	30	1.828355e-2	1.000000e+0	1.000000e+0	5.469397e+1	1.828355e-2	1	1.828355e-2	1.000000e+0	4	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_8H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 8 h.	31	1.839724e-2	1.000000e+0	1.000000e+0	5.435599e+1	1.839724e-2	1	1.839724e-2	1.000000e+0	24	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 1 h versus cDCs infected with Newcastle disease virus (NDV) at 1 h.	32	1.875224e-2	1.000000e+0	1.000000e+0	5.332695e+1	1.875224e-2	1	1.875224e-2	1.000000e+0	1	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	MYLK2
MSigDB Immunologic Signatures	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	Genes up-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	33	1.880210e-2	1.000000e+0	1.000000e+0	5.318556e+1	1.880210e-2	1	1.880210e-2	1.000000e+0	27	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_TH1_DN	Genes down-regulated in comparison of mast cells versus Th1 cells.	34	1.880871e-2	1.000000e+0	1.000000e+0	5.316686e+1	1.880871e-2	1	1.880871e-2	1.000000e+0	15	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 7 versus untreated CD25- T cells at day 7.	35	1.883374e-2	1.000000e+0	1.000000e+0	5.309620e+1	1.883374e-2	1	1.883374e-2	1.000000e+0	45	2.336458e-2	1.000000e+0	9.916966e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE12366_GC_VS_MEMORY_BCELL_UP	Genes up-regulated in comparison of germinal center B cells versus memory B cells.	36	1.883597e-2	1.000000e+0	9.993529e-1	5.308992e+1	1.883597e-2	1	1.883597e-2	1.000000e+0	7	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 2 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h.	37	1.894388e-2	1.000000e+0	9.779138e-1	5.278749e+1	1.894388e-2	1	1.894388e-2	1.000000e+0	10	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MYLK2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_12H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 12 h.	38	1.914558e-2	1.000000e+0	9.623173e-1	5.223139e+1	1.914558e-2	1	1.914558e-2	1.000000e+0	21	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE3982_DC_VS_NKCELL_DN	Genes down-regulated in comparison of dendritic cells (DC) versus NK cells.	39	1.917013e-2	1.000000e+0	9.388448e-1	5.216449e+1	1.917013e-2	1	1.917013e-2	1.000000e+0	3	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 16 h.	40	1.943857e-2	1.000000e+0	9.281917e-1	5.144411e+1	1.943857e-2	1	1.943857e-2	1.000000e+0	10	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN	Genes down-regulated in comparison of splenic secondary CD8 effector T cells at day 8 post-acute infection versus splenic secondary CD8 effector T cells at day 8 post-chronic infection.	41	2.015454e-2	1.000000e+0	9.389066e-1	4.961661e+1	2.015454e-2	1	2.015454e-2	1.000000e+0	15	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_8H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 8 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 8 h.	42	2.041890e-2	1.000000e+0	9.285738e-1	4.897423e+1	2.041890e-2	1	2.041890e-2	1.000000e+0	35	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP	Genes up-regulated in comparison of Ctrlrv versus Foxp3rv (see Fig. 1 in the paper for details).	43	2.047381e-2	1.000000e+0	9.094181e-1	4.884288e+1	2.047381e-2	1	2.047381e-2	1.000000e+0	4	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	MYLK2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 8 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 8 h.	44	2.215767e-2	1.000000e+0	9.618443e-1	4.513109e+1	2.215767e-2	1	2.215767e-2	1.000000e+0	37	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE3982_BCELL_VS_NKCELL_DN	Genes down-regulated in comparison of B cells versus NK cells.	45	2.313552e-2	1.000000e+0	9.819743e-1	4.322358e+1	2.313552e-2	1	2.313552e-2	1.000000e+0	9	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE3982_DC_VS_MAC_DN	Genes down-regulated in comparison of dendritic cells (DC) versus macrophages.	46	2.388663e-2	1.000000e+0	9.918144e-1	4.186442e+1	2.388663e-2	1	2.388663e-2	1.000000e+0	36	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	TPX2
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN	Genes down-regulated in comparison of control dendritic cells (DC) at 2 h versus those stimulated with Pam3Csk4 (TLR1/2 agonist) at 2 h.	47	2.546058e-2	1.000000e+0	1.000000e+0	3.927640e+1	2.546058e-2	1	2.546058e-2	1.000000e+0	21	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	TPX2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
